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ABSTRACT OF THE DISSERTATION 
 
Epidemiological, Environmental, and Biological Risk Factors for Gastroschisis 
by 
Arti Ketan Desai 
Doctor of Philosophy, Graduate Program in Biology 
Loma Linda University, June 2018 
Dr. Bryan T. Oshiro, Chairperson 
 
Gastroschisis, a congenital defect of the abdominal wall, manifests as external 
herniation of viscera, most commonly the fetal bowel. The worldwide prevalence of 
gastroschisis continues to rise, and this increase can also be seen in California with an 
overall birth prevalence of 2-3 per 10,000 births. While the etiology and pathogenesis of 
gastroschisis remains unknown, previous studies indicate several risk factors including 
young maternal age, nulliparity, and low maternal body mass index, in addition to 
environmental factors and exposure, given the increase in global prevalence with a 
predisposition of cases to occur in clusters, and absence of a genetic link. We sought to 
examine etiology of gastroschisis and associated epidemiological, environmental, and 
biological factors by; 1) determining prevalence of gastroschisis in the Inland counties of 
Southern California over time; 2) assessing geospatial patterns with overlays of various 
environmental factors; and 3) comparing cell migration rates from biological samples in 
gastroschisis versus control pregnancies. We found increased maternal age and parity 
over time in those carrying a baby affected by gastroschisis and observed clustering of 
cases in the Inland Empire region. There were no significant differences in cell migration 
rates. Results identified changing prenatal characteristics and potential relationships with 
environmental hazards, which future studies will continue investigating. Continued 
 xvi 
research can aid in improved prenatal diagnosis and better clinical outcomes for the 
mother and baby.   
 
 
 1 
CHAPTER ONE 
INTRODUCTION TO GASTROSCHISIS  
 
Gastroschisis is a congenital birth defect of the abdominal wall resulting in an 
infant’s intestines protruding outside the body through a perforation lateral to the 
umbilicus.1 Numerous studies have shown an increased prevalence of gastroschisis 
throughout the world in the last few decades, and the United States and the State of 
California are no exceptions to this growing trend.3, 4, 7-19 Data from The National Birth 
Defects Prevention Network showed the prevalence of gastroschisis in the United States 
during the years 1999 to 2001 as being 3.73 per 10,000 live births.5 An updated 
publication reporting on data from 2004 to 2006 shows the increase in the prevalence to 
4.49 per 10,000 live births.11 Data from a population-based registry in California from 
1987 to 2003 noted a birth prevalence of 2.57 per 10,000 births. During the 17- year 
study period in the State of California, the overall birth prevalence increased by 3.2-
fold.18 This study by Vu et al. demonstrated that the birth prevalence of gastroschisis has 
been gradually rising in the past two decades in California.  
Furthermore, in San Bernardino and Riverside Counties of Southern California, 
annual rates of gastroschisis were noted as 3.2 and 6.0 per 10,000 live births and fetal 
deaths in the years 2005 and 2006, respectively.19 The multitude of data throughout the 
years show the increased prevalence of gastroschisis on not only a worldwide scale, but 
at a national and state level, as well. In California, in particular the Inland Empire region 
of Southern California, various hypotheses have been proposed regarding the 
pathogenesis, etiology, and risk factors of gastroschisis. Teratogens such as organic 
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solvents, maternal smoking, alcohol, and illicit drugs as associated with gastroschisis.20-24 
Risk factors associated with gastroschisis include young maternal age, nulliparity, 
residences surrounding landfill sites, and low pregnancy body mass index (BMI).18,25,26 
Environmental factors have also been linked to increasing rates of gastroschisis, as 
suggested by prevalence and tendency to occur in clusters.16,27-31 The implication of 
environmental factors is also supported by evidence from animal models.32-38 While the 
etiology of gastroschisis remains unknown, there are several main theories of 
pathogenesis. First is that of teratogenic differentiation of embryonic mesenchyme with 
deficiency of the somatopleure. Deprived of mesenchymal support the somatopleure is 
reabsorbed creating the typical right periumbilical defect.39 Others have suggested a 
modification of this idea, with umbilical ring mesodermal dysplasia that results in 
disruption 40, 41 Alternatively, the cause of gastroschisis may be a vascular developmental 
defect of the omphalomesenteric artery.42 Another theory is that of premature atrophy of 
other abnormality of the right umbilical vein.43, 44 A related suggestion is that 
gastroschisis is a consequence of failure of the yolk sac and related vitelline structures to 
be incorporated into the umbilical stalk.45 Before a specific gene and/or mutation can be 
linked causally to this disorder, its biologic relevance must be established. The critical 
question is not whether cases as a group have more rare events (such as single nucleotide 
polymorphisms, SNP) then controls, but rather which mutation disrupting a gene is 
responsible for the given anomaly. Variable penetrance, epistasis, epigenetic changes 
and/or other gene-environment interactions can complicate this picture.  
Based on previous studies and data it can be hypothesized that demographic, 
social, biological, obstetric, and/or environmental factors may be associated with the 
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prevalence of gastroschisis. Specific objectives will be analyzed to recognize risk factors 
and better understand the pathogenesis and mechanism of gastroschisis in order to reduce 
neonatal health disparities. 
This study, which couple biological tissue sampling and geo-temporal and spatial 
mapping, is needed to move beyond speculation, and potentially lead us to a cause.  
Research which further advances the understanding of risk factors or causative 
mechanisms may ultimately result in the prevention of gastroschisis and its related 
morbidities. Once this is known, we can move forward with potential interventions.  In 
addition, our characterization of patients in a prospective fashion could lead to better 
predictors of neonatal outcomes. By studying long term outcome data on these affected 
individuals, we may be better able to understand their feeding problems and nutritional 
requirements, and design improved treatment programs for them. Lastly, this study serves 
as a tool to educate, and increase awareness and knowledge in the population as a whole, 
about the increasing global prevalence of gastroschisis and its possible causes.  
 
Objective and Aims 
The objective of this dissertation is to examine the etiology of gastroschisis and 
associated epidemiological, environmental, and biological factors. The study has three 
main aims: 1) to determine the prevalence of gastroschisis in the Inland Empire counties 
of Southern California from the period January 1998 to March 2018; and 1.1) to identify 
associations, if any exist, between maternal and infant demographic, social, biological, 
and obstetric factors with the prevalence of gastroschisis; 2) to assess temporal and 
geographic trends to determine geographic clustering of gastroschisis cases and their 
 4 
associations with environmental factors, such as waste disposal sites, water supplies, 
power lines, and toxic chemicals; and 3) to elucidate the etiology of gastroschisis through 
comparison of biological samples from mothers of babies diagnosed with gastroschisis to 
those of uncomplicated pregnancies.  
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CHAPTER TWO 
EPIDEMIOLOGICAL TRENDS OF GASTROSCHISIS 
Introduction 
Epidemiology plays a major role in translational research and translating scientific 
discoveries into clinical practice and population health impact.1 As such, understanding 
and identifying risk factors and maternal characteristics are vital in elucidating etiology 
and pathogenesis of birth defects, such as gastroschisis.  
Birth defects are characterized as structural abnormalities present at birth, 
yielding surgical, medical, or cosmetic importance. In the United States, birth defects 
account for 3% of live births annually. Birth defects are not only the leading cause of 
infant mortality in the United States with 1.2 deaths per 1,000 live births, but are also 
associated with increased morbidity, health care use, and costs. 2  
Gastroschisis is a birth defect of the abdominal wall with increased prevalence in 
the last few decades. Gastroschisis has increased in prevalence worldwide from 
approximately 0.1 per 10,000 total births in the 1970s to over 5 per 10,000 total births in 
the early 2000s.3, 4 The Center for Disease Control notes an increased prevalence of 
gastroschisis by 30% in the United States from 3.6 per 10,000 births during 1995–2005 to 
4.9 per 10,000 births during 2006–2012. Increased prevalence and limited understanding 
of risk factors pose concerns and an urgency to identify the causal factors contributing to 
this increase. 5 The overall neonatal mortality rate for gastroschisis is 5–10%, and 
associated morbidities, such as susceptibility to sepsis can lead to additional 
complications and prolonged hospitalization stays in gastroschisis patients.6 As 
gastroschisis cases continue to increase, understanding the best management is essential 
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in improving neonatal outcomes. We sought to gain a better understanding of 
gastroschisis risk factors by first looking at various factors and trends associated with 
gastroschisis and its increased prevalence over time in the Inland Empire region of 
Southern California. We then looked at long term outcomes in neonates with 
gastroschisis to identify how these babies do over time depending on mode of delivery 
and type of closure at Loma Linda University Children’s Hospital.  
 
Does Time Really Tell All? Investigating the Relationship of Time on Maternal Age 
and Parity in Gastroschisis Cases 
A retrospective chart review was performed on cases of gastroschisis (n= 257) in 
order to determine rates during a 14-year time period (1998-2012) at Loma Linda 
University Medical Center located in California's Inland Empire region. Maternal factors 
of age and parity were assessed to determine if longitudinal trends exist. The mean for 
each year was plotted for each of these variables and correlation models were generated 
to determine if longitudinal changes in these risk factors were present. Simple linear 
regression analysis was performed for maternal age and parity. Figure 2.1 shows results 
depicting a line of best fit for maternal age with an R2 value of 0.215 and a Pearson 
Coefficient of 0.464 with a significance of 0.082. Figure 2.2 shows a line of best fit for 
maternal parity shows an R2 value of 0.251 and a Pearson Coefficient of 0.501 with a 
significance of 0.057.  
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Figure 2.1. Linear regression analysis of maternal age over time. 
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Figure 2.2. Linear regression analysis of maternal parity over time. 
 
 
Cumulative maternal age and parity were higher than anticipated compared to 
previously published reports. Our longitudinal analysis showed an increase in maternal 
age and parity over time suggesting a shift in these risk factors over the past 14 years. 
This trend has also been noticed clinically. The results of this study allow us to recognize 
the changing risk factors for gastroschisis, leading to earlier prenatal diagnosis, improved 
clinical care, and decrease in morbidity associated with this disease.  
 
 
Cesarean Sections May Increase the Risk of Sepsis in Neonates with Gastroschisis 
 
In order to optimize management of neonates with gastroschisis we evaluated the 
risk of culture-proven sepsis based upon the mode of delivery. Additionally, we 
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investigated the effect of sepsis and mode of delivery on length of stay (LOS). A 
retrospective chart review was performed on records of 164 mothers that delivered babies 
with gastroschisis at Loma Linda University Medical Center and Lucile Packard 
Children’s Hospital Stanford from February 1999 to December 2012. Institutional review 
board (IRB) approval was attained for this study at both Loma Linda University and 
Stanford University. Both institutions utilized Research Electronic Data Capture 
(REDCap), a secure, web-based research data collaborative platform as a means to collect 
and manage study data.7   
Outcomes: The study’s main endpoint consisted in culture proven sepsis, while 
the secondary endpoint was in hospital length of stay (LOS).  
Main exposure: The main exposure in this research was mode of delivery defined 
as vaginal delivery (V), cesarean section with labor (CS&L) and cesarean section without 
labor (CS).  
Covariates: Covariates that were considered for this study included maternal 
characteristics such as diagnosis of urinary tract infection, chlamydia, gonorrhea, and 
genital herpes, as well as delivery characteristics, such as meconium staining and preterm 
delivery.  
Statistical analysis: Crude analyses for the association between mode of delivery 
and each of the covariates with sepsis diagnosis were conducted using chi-squared test. 
Sepsis was a common event (>10% of study population); therefore, covariates adjusted 
relative risk of sepsis with 95% confidence intervals was conducted using log-binomial 
regression.  Final models were built using the purposeful model selection approach with 
mode of delivery, chlamydia, genital herpes and urinary tract infection (UTI) retained for 
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the assessment of the risk of sepsis, while mode of delivery and chlamydia were retained 
for the assessment of in-hospital length of stay. Model assessment did not reveal any 
major outlier and multicollinearity assessment using linear regression did not reveal high 
correlation between covariates.  
 Study population: Among the 164 neonates included in this research, 85 percent 
(51.8%) were V while 42 (25.6%) had CS&L and 37 (22.6%) had CS. Sepsis diagnosis 
was made for 57 (34.8%) including 12 ,26 and 19 that had been delivered by CS, CS&L, 
and V, respectively (Table 2.1).  
Effect of mode of delivery on the risk of sepsis: Compared to V, neonates 
delivered by CS were 2.5 times more likely to develop sepsis during their hospital stay 
RR= 2.65 (1.67-4.21) while those delivered with CS&L had a 52 percent albeit not 
statistically significant increase in the risk of sepsis RR= 1.52 (0.83-2.79) (Table 2.2). 
Effect of chlamydia on the risk of sepsis: Neonates whose mothers were diagnosed 
with chlamydia had RR for sepsis of 1.80 (1.08-3.00) (Table 2.2).  
LOS in neonates delivered by CS&L and CS were 15 (-31 to 0.55) days and 6 (-
22 to 9) days shorter, respectively, compared to V. Neonatal sepsis increased LOS by 50 
(35 to 63) days compared to neonates without sepsis.  
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Table 2.1. Population characteristics by sepsis status (Yes vs. No) 
Characteristics  Sepsis   
  Yes No Total  P-value* 
Mode of delivery        <0.0001 
C-section without labor 
(CS) 
12 (21.1%) 25 (23.4%) 37   
C-section with labor 
(CS&L) 
26 (45.6%) 16 (15.0%) 42   
Vaginal delivery (V)  19 (33.3%) 66 (61.7%) 85   
PPROM       0.9869 
Yes 9 (15.8%) 17 (15.9%) 26   
No 48 (84.2%) 90 (84.1%) 138   
Meconium Staining       0.0945 
Yes 36 (67.9%) 50 (53.6%) 86   
No 17 (32.1%) 43 (46.2%) 60   
Smoking       0.2571 
Yes 4   (7.3%) 14 (13.2%) 18   
No 51 (92.7%) 92 (86.8%) 143   
Illicit Drug Use       0.7765 
Yes 4   (7.1%) 9   (8.4%) 13   
No 52 (92.9%) 98 (91.6%) 150   
Alcohol       0.2531 
Yes 1  (1.8%) 6   (5.6%) 7   
No 55 (98.2%) 101 (94.4%) 156   
Chlamydia       0.0157 
Yes 7 (12.3%) 3   (2.8%) 10   
No 50 (87.7%) 104 (97.2%) 154   
Gonorrhea       0.6487 
Yes 1   (1.8%) 1   (0.9%) 2   
No 56 (98.3%) 106 (99.1%) 162   
Genital Herpes        0.2414 
Yes 2   (3.5%) 1   (0.9%) 3   
No 55 (96.5%) 106 (99.1%) 161   
UTI        0.048 
Yes 3   (5.3%) 16 (15.0%) 19   
No 54 (94.7%) 91 (85.1%) 145   
Preterm Delivery        0.7917 
< 37 weeks  30 (52.6%) 54 (50.5%) 84   
37 weeks + 27 (47.4%) 53 (49.5%) 80   
Length of Stay 85 days (59) 36 days (25)    <0.0001 
Ethnicity       0.6762 
Hispanic 41 (73.21) 75 (70.09) 116   
Non-Hispanic  15 (26.79) 32 (29.91) 47   
Some categories do not add up to 164 due to missing observations.  
*Chi-square test of independence p-value.  
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Table 2.2. Relative risk of sepsis for mode of delivery and chlamydia 
 
Risk factors  RR (95% CI) 
Mode of delivery  
C-section without labor (CS) 2.65 (1.67-4.21) 
C-section with labor (CS&L) 1.52 (0.83-2.79) 
Vaginal delivery (V)  Reference 
Chlamydia  
Yes 1.80 (1.08-3.00) 
No Reference 
 
 
While the safest delivery method in gastroschisis cases remains controversial, 
previous studies have compared vaginal deliveries to cesarean deliveries, yet failed to 
investigate cesarean deliveries with labor and the corresponding neonatal outcomes. 8 Our 
study compared neonatal outcomes through sepsis rates and length of stay in patients 
delivered vaginally, by cesarean section with labor, and cesarean section without labor. 
Neonates with gastroschisis showed a significantly increased risk of sepsis when 
delivered by CS&L. Neonates delivered by CS&L were over 2 times more likely to 
develop sepsis, which can then lead to further complications; however, their LOS was 
shorter compared to V. Also, neonates delivered to mothers with chlamydia showed a 
significantly greater risk of sepsis. 
It is important to note that multiple factors, including surgeon preference, fetal 
responses nearing time of delivery, and defect severity all play a role in mode of delivery 
considerations for those babies with gastroschisis. Nonetheless, our results revealed   
increased sepsis in those delivered by CS&L.   Fetal intolerance of labor, or alterations in 
the vaginal flora exposure in these neonates may have contributed to the increased sepsis 
rate. The increased rate of sepsis and sepsis-related complications also contributed to 
increased LOS.  
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Longitudinal, outcomes-based studies are essential in understanding additional 
complications related to gastroschisis and utilizing best practice approaches to ensure 
safety for both mother and baby.  
 
Delayed Closure Increases the Risk of Sepsis and Length of Stay in Neonates with 
Gastroschisis 
Neonates with gastroschisis undergo primary or delayed closure. We sought to 
determine whether there was any difference in neonatal sepsis based upon the closure 
strategy. Additionally, we investigated the effect of sepsis and type of closure on length 
of stay (LOS).    
The records of neonates with gastroschisis managed at Loma Linda University 
Medical Center and Lucile Packard Children’s Hospital Stanford from February 1999 to 
December 2012 were reviewed (n=152). The closure type was classified as: primary 
fascial closure (P/F) and initial silo closure with staged fascial closure (S). Primary 
outcome was culture proven sepsis and secondary outcome was LOS. Sepsis rates by type 
of closure were assessed. Crude log-binomial risk ratios (RR) and 95% confidence 
intervals (CI) were reported for the presence of chlamydia, gonorrhea, genital herpes, 
urinary tract infections, preterm premature rupture of membranes, preterm delivery, 
intrauterine growth restriction, meconium staining, Hispanic ethnicity, and abuse of any 
of the following substances: tobacco, illicit drugs, or alcohol. The effects of sepsis and 
type of closure on LOS were assessed using multiple linear regression. The distribution 
of closure strategies was as follows: P/F=44 and S=108 (Table 2.3). Sepsis incidence was 
83% higher in S compared to P/F, RR=1.83 (1.02-3.30) (Table 2.4). The risk of sepsis 
was doubled among neonates delivered to mothers with chlamydia RR=2.07 (1.30-3.30).  
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Table 2.3. Population characteristics by sepsis status (Yes vs. No) 
Characteristics  Sepsis       
  Yes No Total 
 P-
value* 
RR      (95% CI) 
Type of Closure        0.0275    
Primary (P/F) 10 (18.2%) 34 (35.1%) 44   1   
Silo (S) 45 (81.8%) 63 (65.0%) 108   1.83 1.02 3.30 
Chlamydia       0.0213      
Yes 7 (12.3%) 3   (3.1%) 10   2.07 1.30 3.30 
No 48 (87.3%) 94 (96.9%) 142   1     
Gonorrhea       0.6823      
Yes 1   (1.8%) 1   (1.0%) 2   1.39 0.34 5.64 
No 54 (98.2%) 96 (99.0%) 150   1     
Genital Herpes        0.2671      
Yes 2   (3.6%) 1   (1.03%) 3   1.87 0.82 4.30 
No 53 (96.4%) 96 (99.0%) 149   1     
UTI        0.048      
Yes 3   (5.5%) 16 (16.5%) 19   0.40 0.14 1.17 
No 52 (94.5%) 81 (83.5%) 133   1     
PPROM       0.7515      
Yes 8 (14.6%) 16 (16.5%) 24   0.91 0.49 1.67 
No 47 (85.5%) 81 (83.5%) 128   1     
Preterm Delivery        0.9398      
< 37 weeks  28 (50.9%) 50 (51.6%) 78   0.98 0.65 1.50 
37 weeks + 27 (49.1%) 47 (48.5%) 74   1     
IUGR    0.0308      
Yes 17 (30.9%) 47 (49.0%) 64  0.61 0.38 0.98 
No 38 (69.1%) 49 (51.0%) 87  1     
Meconium 
Staining 
      0.2114      
Yes 35 (68.6%) 48 (57.8%) 83   1.34 0.83 2.17 
No 16 (31.4%) 35 (42.2%) 51   1     
Substance Abuse       0.1727      
Yes 7 (12.7%) 21 (21.7%) 28   0.65 0.33 1.27 
No 48 (87.3%) 76 (78.4%) 124   1     
Length of Stay 
86 days 
(±59) 
37 days 
(±25) 
   <0.0001      
Ethnicity       0.7836      
   Hispanic 39 (72.22) 68 (70.10) 107   0.94 0.58 1.51 
   Non-Hispanic  15 (27.78) 29 (29.90) 44   1     
Some categories do not add up to 152 due to missing observations.  
*Chi-square test of independence p-value.  
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None of the other covariates showed a significant effect on neonatal sepsis. An increase 
of 26 (11.89, 39.99) days was observed for neonates with S compared to P/F, while sepsis 
increased LOS by 45 (31.55, 58.07) days.  
 
 
Table 2.4. Mean length of stay as predicted by  
sepsis diagnosis and Type of Closure. 
 
Parameter Mean LOS ( 95% CI) 
Intercept 20.02 (7.98, 32.06) 
Type of 
Closure 
 
Silo (S) 25.94 (11.89, 39.99) 
Primary 
(P/F) 
Reference 
Sepsis  
Yes 44.81 (31.55, 58.07) 
No Reference 
 
 
 
There is a significant increase in both the risk of sepsis and LOS associated with S 
compared to P/F, but further investigations are warranted to elucidate these effects. It is 
important to note that often times closure methods depend on pediatric surgeon 
preference and severity of defect opening and gut and/or organ protrusion. Understanding 
the effects various treatments play in outcomes of neonates with gastroschisis helps us 
understand the complexities and long term effects associated with this defect.     
 
Outcomes of Infants Born with Gastroschisis at 12 Months of Age: A Prospective 
Cohort in Southern California 
Given that gastroschisis is the most common birth defect of the abdominal wall, 
and its prevalence has risen on both global and local scales throughout the last few 
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decades we sought to study the long term morbidities associated with gastroschisis and to 
determine if there are prognostic factors that may predict adverse outcomes in affected 
infants.  
Our objective of this study was to follow infants affected by neonatal 
gastroschisis prospectively to determine long-term outcomes. Specifically, our aim was to 
determine if there are factors at birth or during the immediate neonatal period related to 
poor long-term outcomes in infants with gastroschisis. 
A prospective cohort study was performed on cases of gastroschisis at Loma 
Linda University Children’s Hospital located in California’s Inland Empire Region. 
Study participants were enrolled beginning in 2014, after this study received IRB 
approval.  Informed consent was obtained from all study participants. Infants included in 
the study included all study participants who were live born and greater than 12 months 
of age at the time of chart review. Thirty-three infants were included, and one intrauterine 
fetal death (IUFD) was excluded. Infants who were enrolled in the study were excluded if 
they were less than 12 months of age at the time of chart review. Maternal and infant 
factors were assessed including: maternal pregnancy complications, maternal GBS status, 
gestational age at delivery, mode of delivery, weight category at delivery, type of 
gastroschisis, timing of closure, closure type, time to full enteral feeds, and postnatal 
complications. Infants were divided into the categories of good outcomes and poor 
outcomes based upon the number of postnatal complications. Infants with less than 3 
postnatal complications were placed in the good outcome category. Infants with 3 or 
more postnatal complications were placed in the poor outcome category. Among the 33 
infants that were included in the study, 18 infants were classified as having a good 
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outcome and 15 infants were classified as having a poor outcome.  The groups were 
compared to determine if there was statistical difference between the groups. Chi squared 
test was used to determine if there was statistical difference between nominal data, and t-
test was used to determine if there was statistical difference between numerical data. In 
the poor outcome group there was significantly more infants with complex gastroschisis 
(p = 0.006).  Additionally, infants in the poor outcome group had significantly longer 
time to full feeds, with a mean of 122 days compared to 24 days in the good outcome 
group. The poor outcome group was noted to have more deliveries via cesarean section, 
although p = 0.06, which did not meet our cut-off for statistical significance. Although 
this may be due to small sample size, as it appears data are trending towards significance.  
The timing of closure was not significantly different (p = 0.17) between infants 
with good and poor outcomes, and no significant difference (p = 0.14) was noted between 
weight category at time of birth or maternal GBS status (p = 0.95).  
The strength of this study is that subjects were prospectively enrolled and followed. The 
limitations of this study are the relatively short duration follow-up, the small sample size, 
and loss of patients during follow-up visits.  
Nonetheless, we noted that complex gastroschisis and delayed time to full feeds 
are associated with poor outcomes at greater than one year of life. Additionally, infants 
that are delivered via cesarean section may be at higher risk for poor long-term outcomes 
of the disease. Long term follow-up data will aid in identifying prognostic facts and aid in 
counseling for families affected by gastroschisis. 
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Abstract 
 
Purpose: Gastroschisis is a birth defect of the abdominal wall. While the 
incidence of gastroschisis has increased globally in recent years, only a few familial 
recurrent cases have been reported. Methods: A cohort study was performed to 
determine the sibling recurrence rate of gastroschisis at our tertiary care medical center 
located in Southern California. 186 neonates with gastroschisis were delivered from 
2003-2015 to 183 mothers. Among these mothers, 55 were multiparous and therefore 
included in calculating the rate of gastroschisis occurring in siblings. Primiparous women 
were excluded from this study. Results: Of 55 multiparous women included in the study, 
3 women had pregnancies affected by recurrent gastroschisis. This represents a 5.45% 
sibling recurrence rate of gastroschisis in our study cohort. Conclusions: Literature has 
failed to demonstrate hereditary factors in gastroschisis pathogenesis. However, the 
recurrence rate of familial gastroschisis suggests that women with a history of a prior 
neonate with gastroschisis may be at a higher risk than previously noted. Therefore, 
families with a history of gastroschisis may benefit from pre-conceptional counseling to 
discuss the higher risk of gastroschisis in a future pregnancy. Expectant mothers who 
have had a pregnancy complicated by gastroschisis should undergo early ultrasound and 
counseling to ensure the best management of care for mother and neonate. 
 
Introduction 
 
Gastroschisis is a birth defect of the abdominal wall where an infant’s intestines 
protrude outside of the body usually through an opening to the right of the umbilical cord. 
1, 2  Studies show an increased prevalence of gastroschisis on both global and local scales 
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throughout the last few decades. 3-9  The prevalence of gastroschisis is usually noted as 
0.5- 1 cases per 10,000 live births, yet in England the incidence of gastroschisis doubled 
in about a decade span (1987-1995) to 1.35 per 10,000 births and in Southwestern 
England the incidence has been as high as 4.4 per 10,000 births. 6 Mexico noted an 
increased prevalence from 2.09 per 10,000 live births in 2000 to 6.85 per 10,000 in 
2014.8 In the United States, the state of California and its Inland Empire counties are no 
exception to this trend.9-18 In one of the largest studies conducted in the United States, 
researchers found the prevalence of gastroschisis nearly doubled from 1995 to 2005, 
increasing from 2.3 per 10,000 live births in 1995 to 4.4 per 10,000 live births in 2005. 16 
Additionally, a 17-year study (1987 to 2003) utilizing data from the California Birth 
Defects Monitoring Program concluded that the overall birth prevalence of gastroschisis 
increased by 3.2-fold and continues to increase in California. 17 Specifically, in San 
Bernardino and Riverside Counties of Southern California annual rates of gastroschisis 
were noted as 3.2 and 6.0 per 10,000 live births in the years 2005 and 2006, 
respectively.18  
While the prevalence of gastroschisis has increased globally in recent years, its 
etiology and pathogenesis remain unknown. 1-3, 19, 20 Many studies have considered 
genetic and environmental factors. For instance, demographics, such as young maternal 
age, low gravidity and parity, low socioeconomic status, and maternal smoking have been 
proposed, yet no strong associations have been identified and proven true. 2, 14, 16-22    
Interestingly, a few familial recurrent cases are reported. Specifically, a familial 
recurrence risk of 2.4% was calculated by Kohl et al, from population-based registries 
where 10 familial cases were noted amongst 412 gastroschisis births. 19 Additionally, a 
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study by Torfs and Curry noted a familial recurrence risk of 4.7% where 6 out of 127 
families had more than one relative affected by gastroschisis and a sibling recurrence risk 
of 3.5%. 21    
Given that the incidence of gastroschisis has increased globally in recent years, 
and identification of various risk factors have not yet led to concrete etiology, 
understanding familial recurrence risk is a step towards preventing poor outcomes. With 
familial recurrence rates of gastroschisis more frequent than previously noted, expectant 
mothers who have had a pregnancy complicated by gastroschisis or have had a family 
member with gastroschisis should undergo early ultrasound and counseling to ensure the 
best management of care for mother and neonate. 
 
Material and Methods 
A cohort study was performed to determine the sibling recurrence rate of 
gastroschisis at Loma Linda University Children’s Hospital, a tertiary care medical center 
located in Southern California. We identified the delivery of 186 neonates with 
gastroschisis from 2003-2015 to 183 mothers. Among these mothers, 55 were 
multiparous, and therefore included in calculating the rate of gastroschisis occurring in 
siblings, while the remaining primiparous women were excluded from this study.  
 
Results 
Of the 55 multiparous women included in the study, three women had 
pregnancies affected by recurrent gastroschisis, representing a 5.45% sibling recurrence 
rate of gastroschisis in our study cohort. Further investigation showed one patient was a 
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19-year-old G3P0212 who delivered a female neonate affected by gastroschisis in 
11/2009, and subsequently delivered a male neonate affected by gastroschisis in 12/2010. 
A second patient was a 21-year-old G3P1202 who delivered a female neonate in 1/2006 
affected by gastroschisis, a female neonate not affected by gastroschisis in 8/2006 which 
resulted in neonatal death, and subsequently delivered a female neonate in 9/2009 
affected by gastroschisis. The third patient was a 21-year-old G2P2002 who delivered a 
female neonate in 2/2011 affected by gastroschisis, and subsequently delivered a female 
neonate in 10/2015 affected by gastroschisis. (Table 2.5). 
 
Table 2.5. Sibling recurrences of gastroschisis reported from 2003- 2015 at Loma 
Linda University Children’s Hospital 
 
 
 
 
 
Discussion 
While literature has failed to demonstrate hereditary factors in gastroschisis 
pathogenesis, the recurrence rate of familial gastroschisis suggests that women with a 
history of a prior neonate with gastroschisis or with a family history of gastroschisis may 
be at higher risk than previously noted. A 5.45% recurrence rate was noted during our 
cohort study, corroborating recurrence trends previously noted.  
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These observations are met with a few limitations. While our 13-year tracking 
yielded a robust sample size, these patients are limited to Southern California’s Inland 
Empire region and its surrounding referral area. Next, in collecting family history, often 
times it was noted that medical records only provided brief medical histories and/or a 
patient was unaware of their extended family history. Also, unidentified paternal identity 
and unknown paternal family history provides an incomplete neonatal pedigree. Further 
studies should try to obtain more comprehensive patient and family histories, and even 
longitudinally track families with a pregnancy affected by gastroschisis to see the 
outcome of subsequent pregnancies. In conclusion, families with a history of 
gastroschisis may benefit from pre-conceptual counseling to discuss the higher risk of 
gastroschisis in a future pregnancy. Expectant mothers who have had their own previous 
pregnancy or that of a family member complicated by gastroschisis should undergo early 
ultrasound and counseling to ensure the best management of care for mother and neonate. 
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Abstract 
Objectives Neonates with gastroschisis are often small for gestational age (SGA) 
based on population nomograms. Our objective was to evaluate the effect of SGA on 
perinatal and neonatal outcomes in cases of gastroschisis. Methods This is a 
retrospective study of neonates with prenatally diagnosed gastroschisis from two 
academic centers between 2008 and 13. Perinatal and neonatal outcomes of neonates with 
SGA at birth were compared with appropriate-for-gestational-age (AGA) neonates. The 
primary composite outcome was defined as any of the following: neonatal sepsis, short 
bowel syndrome at discharge, prolonged mechanical ventilation (upper quartile for the 
cohort), bowel atresia or death. Results We identified 112 cases of gastroschisis, 25 of 
whom (22%) were SGA at birth. There were no differences in adverse peripartum 
outcomes between SGA and AGA infants. No difference was found in the primary 
composite neonatal outcome (52% vs 36%, p = 0.21), but SGA infants were more likely 
to have prolonged mechanical ventilation (44% vs 22%, p = 0.04) and prolonged length 
of stay (LOS) (52% vs 22%, p = 0.007). After adjusting for GA at delivery, SGA 
remained associated with prolonged LOS (OR = 4.3, CI: 1.6–11.8). Conclusion Among 
infants with gastroschisis, SGA at birth is associated with a fourfold increase in odds for 
prolonged LOS, independent of GA. 
 
Introduction 
Gastroschisis is a severe paraumbilical defect of the fetal abdominal wall that 
occurs in approximately one to five cases per 10 000 live births.1 Fetal gastroschisis is 
commonly diagnosed in utero by routine ultrasound that identifies the defect with high 
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sensitivity and specificity starting as early as the first trimester.2,3 Although the overall 
neonatal mortality among gastroschisis cases is low,4 pregnancies with gastroschisis are 
at increased risk for severe peripartum complications including meconium staining, 
intrauterine growth restriction (IUGR) and stillbirth, as well as neonatal gastrointestinal 
morbidities including bowel dysfunction, bowel atresia, bowel necrosis and short-bowel 
syndrome.5  
Prior studies have identified the association between gastroschisis and prenatally 
suspected IUGR and small for gestational age (SGA) at delivery.6,7 It has been reported 
that pregnancies complicated by IUGR are more likely to result in increased neonatal 
morbidity, including increased surgical complications, longer hospital stay, delay in 
establishment of full enteral feeds and impaired long-term growth.8–11 However, because 
of the underestimation of the fetal abdominal circumference by prenatal ultrasound using 
most estimated fetal weight formulas,12 the false positive rates for suspected IUGR 
diagnosis may be high and a misdiagnosis may lead to unnecessary iatrogenic preterm 
delivery and related morbidities. Moreover, prenatal prediction of SGA is erroneous even 
in non-gastroschisis cases.13,14 Therefore, understanding the association between ‘true 
SGA’ at birth and perinatal and neonatal outcomes in cases of gastroschisis is warranted. 
Our aim was to evaluate the association between SGA and perinatal and neonatal 
outcomes in cases of prenatally diagnosed gastroschisis. 
 
Materials and Methods 
Study population This was a retrospective cohort study of all infants with 
prenatally diagnosed gastroschisis whose mothers received prenatal care at Loma Linda 
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University Medical Center and Lucile Packard Children’s Hospital at Stanford between 
2008 and 2013. Both institutions are tertiary care referral centers in California with 
maternal–fetal medicine, prenatal ultrasound, level IV neonatal intensive care units and 
pediatric surgical expertise in managing gastroschisis.  
Gastroschisis cases were identified from separate institutional databases in which 
pregnancies with fetal anomalies are prospectively entered. Only cases with information 
on SGA diagnosis were included in the analysis. In both institutions, pregnancies 
complicated by fetal gastroschisis are managed in outpatient high-risk pregnancy clinics, 
with serial ultrasound surveillance and antenatal non-stress testing. Indications for 
delivery prior to 37 completed weeks gestation are severe maternal medical or obstetric 
complications, or non-reassuring fetal status including suspected IUGR or abnormal 
antenatal testing. In the absence of associated fetal or maternal morbidity, delivery for 
gastroschisis cases is recommended between 36 and 37 completed weeks in both 
institutions in order to avoid early term stillbirth, the precise timing of which is left to the 
discretion of the primary care provider. A trial of labor is preferred over cesarean 
delivery in the absence of obstetric contraindications.  
Study data from both institutions were collected and managed using Research 
Electronic Data Capture (REDCap), 15 a secure, Web-based application designed to 
support data capture for research studies. Institutional review board approval from both 
Loma Linda University and Stanford University was obtained prior to initiation of the 
study.  
Study definitions Detailed perinatal, intrapartum and neonatal variables were collected 
from electronic medical records. In addition, ultrasound reports and stored ultrasound 
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images were reviewed by trained research nurses and physicians. A prenatal diagnosis of 
suspected IUGR was made based on ultrasound estimation of fetal weight less than 10% 
by Hadlock formula, 16 with or without the presence of oligohydramnios and/or umbilical 
artery Doppler abnormalities. Doppler abnormalities in the ductus venosus, umbilical 
vein or middle cerebral artery are not routinely performed in prenatally diagnosed cases 
of fetal gastroschisis in either center, 17 and umbilical artery Doppler assessment is only 
performed in cases of suspected IUGR. Maternal pre-pregnancy body mass index (BMI) 
was calculated as (BMI=weight in kilograms/height^2 in meters) using height and 
documented weight at pre-pregnancy.  
Small for gestational age was defined by a birth weight less than 10th percentile at 
delivery using the Fenton growth charts for infants <38 weeks GA18 and the WHO 
growth charts for infants ≥38 weeks GA.19 Neonatal prolonged length of stay (LOS) was 
defined a priori as the upper quartile (>75th percentile) of LOS (in days) for the entire 
cohort. Prolonged mechanical ventilation was defined similarly a priori as the upper 
quartile of the length of mechanical ventilation for the cohort. Neonatal sepsis or 
infection diagnosis was based on a positive blood culture during initial neonatal 
hospitalization.  
The primary outcome of the study was a composite neonatal outcome, defined as 
any of the following: any culture-positive sepsis or infection, short bowel syndrome at 
discharge (defined clinically by the neonatologist and/or surgeon as recorded in medical 
record), prolonged mechanical ventilation, bowel atresia (as documented in the medical 
record by the neonatal or surgical teams) or death prior to discharge. Secondary outcomes 
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were the individual components of the primary outcome (listed earlier), prolonged 
hospital LOS and prolonged mechanical ventilation requirement.  
Statistical analysis Statistical analysis was performed using R application (version 2.15.0, 
R Development Core Team, 2011, Vienna, Austria). Unadjusted analyses were performed 
using chi-squared test or Fisher’s test for categorical variables and Student’s t-test or 
Wilcoxon test for continuous variables. Sensitivity and specificity analyses were 
performed in subgroups of pregnancies with prenatal ultrasonography performed within 
14 and 7 days prior to delivery, respectively. Multivariable logistic regression models 
were constructed to determine the independent association of SGA with neonatal 
outcomes while adjusting for GA. Results of the model were expressed as odds ratios 
(OR) and 95% confidence intervals (CI). The level of significance was set at p<0.05. 
 
Results 
A total of 112 cases of prenatally diagnosed gastroschisis were identified and 
included in the analysis, of which 25 neonates (22%) were diagnosed with SGA at 
delivery. Of the 25 SGA neonates, 17 (68%) had a birth weight <10th percentile and 8 
(32%) had birth weight <3rd percentile. There were no cases of antepartum or peripartum 
stillbirth, and all cases had both perinatal and neonatal data available for analysis. No 
significant differences were seen in maternal age, race/ethnicity, payer status, study 
center, gravidity or parity, pre-pregnancy BMI or smoking between the SGA and 
appropriate-for-gestational-age (AGA) groups (Table 2.6).  
Neonates that were SGA had similar peripartum complication rates when 
compared with AGA neonates. There were no differences in meconium staining at 
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delivery, gestational age at delivery, oligohydramnios rated, preterm premature 
membrane rupture (PPROM) rates, preterm delivery less than 37 weeks or cesarean 
delivery between the two groups (Table 2.7). Prenatal IUGR diagnosis was suspected in 
76% of the SGA neonates compared with 41% in the AGA cohort (p = 0.005) but the 
incidence of abnormal umbilical artery Doppler flow was not different between the 
groups (8% vs 0% in AGA, p = 0.07) (Table 2.7).We analyzed cases that underwent an 
ultrasound exam within 14 days of delivery (n = 65) and found the sensitivity and 
specificity of suspected IUGR diagnosis to be 100% and 42%, respectively. When 
limiting the analysis to those undergoing an ultrasound exam within 7 days of delivery (n 
= 33), the sensitivity and specificity were 100% and 35%.  
Small-for-gestational-age neonates had a significantly smaller mean birth weight 
at delivery compared with AGA neonates (2051 ± 268 g vs 2639 ± 425 g, p<0.0001), 
although no differences in the gestational age at delivery or 5 min Apgar scores were 
seen (Table 2.8). No significant difference was seen in the unadjusted rate of the primary 
composite outcome between the SGA and AGA groups (52% vs 36%, p = 0.21). 
Although no significant difference was found in absolute hospital LOS or length of 
mechanical ventilation, the SGA neonates were more likely to have prolonged hospital 
stay, which was ≥53 days (52% vs 22%, p<0.01) and prolonged mechanical ventilation 
(≥11 days; 44% vs 22%, p = 0.04) compared with AGA neonates. There were no 
differences in the type of closure performed, with 32% achieving primary closure in the 
SGA group and 37% in the AGA group, p = 0.84. There was also no difference in the 
incidences of bowel atresia (0% vs 7%, p = 0.43) or neonatal sepsis (32% vs 20%, p = 
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0.30) between the SGA and AGA groups (Table 2.8). One neonatal death occurred in the 
AGA group at the age of 46 days.  
A multivariable logistic regression analyses were then performed in order to 
assess the association between neonatal outcomes and SGA, adjusting for gestational age 
at delivery (Table 2.9). The odds for prolonged LOS were significantly increased in SGA 
neonates compared with AGA neonates (adjusted OR: 4.3, 95% CI: 1.3–15.3). In 
addition, the odds of prolonged mechanical ventilation were higher in SGA neonates (OR 
= 3.0, CI: 1.1–8.1) compared with AGA neonates. No significant association was found 
between SGA and primary composite outcome, culture proven sepsis/infection or preterm 
delivery at <37 weeks gestation (Table 2.9).  
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Table 2.6. Maternal demographics in cases of small-for- 
gestational-age neonates (SGA) compared with appropriately 
grown (AGA) neonates with gastroschisis 
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Table 2.7. Perinatal outcomes of small-for-gestational-age (SGA) 
neonates compared with appropriately grown (AGA) neonates 
with gastroschisis 
 
 
 
 
 
 
 
 
 
 42 
Table 2.8. Neonatal outcomes of small-for-gestational-age 
(SGA) neonates compared with appropriate-for-gestational-age 
(AGA) neonates with gastroschisis 
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Table 2.9. Association between neonatal outcomes and SGA 
among infants with gastroschisis 
 
 
Discussion 
The prevalence of fetal gastroschisis is increasing. In a recent study of over 13 
million live births from 15 states, 4713 of whom were complicated by fetal gastroschisis, 
a consistent increase in the prevalence of gastroschisis was noted from 2.32 per 10000 
births in 1995 to 4.42 per 10 000 in 2005.1 This increase is particularly worrisome given 
the association between gastroschisis and severe peripartum and neonatal morbidity and 
mortality. In this study, we evaluated the effect of SGA on perinatal and neonatal 
outcomes in cases of prenatally diagnosed gastroschisis using a cohort from two tertiary 
care centers in California and found that prolonged length of stay was significantly 
associated with SGA compared with AGA, independent of gestational age.  
The association between gastroschisis and SGA at delivery is well established, 
with most studies describing an approximate 20% rate of SGA20 while much higher rates, 
up to 40–60%, have also been described in gastroschisis.21,6,22 Reasons for differences in 
these rates are unclear and may be related to different definitions of SGA (<3% vs 
<10%), different maternal baseline demographics and potential differences in exposure to 
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environmental toxins, some of which have been linked with the development of 
gastroschisis.23 Our cohort comprised mostly young nulliparous women with relatively 
low pre-pregnancy BMI, and the maternal smoking rate of 15% in our cohort is slightly 
higher than that generally seen in California.24  
The current study provides important and robust data regarding the association 
between SGA at birth and both perinatal and neonatal outcomes not previously described. 
In our cohort, we did not find a higher rate of adverse perinatal outcomes including 
meconium staining, PPROM, preterm delivery or cesarean delivery when comparing 
SGA neonates with their AGA counterparts. Although SGA is by large postulated to be 
placentally mediated, in this study the lack of difference in perinatal outcomes between 
those with and without growth restriction suggests that some of the fetuses with 
suboptimal growth may have been constitutionally small rather than pathologically grown 
due to abnormal placentation.25 Also, mothers of SGA neonates had similar pre-
pregnancy BMI, smoking status and parity when compared with mothers of AGA 
neonates. Unfortunately, placental pathological assessment was not routinely performed 
in our cohort, and further studies are necessary to characterize possible pathological 
mechanisms leading suboptimal growth in gastroschisis cases.  
From a neonatal perspective, SGA neonates did experience a longer hospital 
length of stay and prolonged mechanical ventilation when compared with those who were 
AGA, but we did not find a similar association with other neonatal morbidities, including 
the composite adverse neonatal outcome. In a recent study of 191 gastroschisis cases 
from the University of California database, SGA was not found to be associated with a 
composite neonatal outcome including death, bowel complications requiring reoperation, 
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gastrostomy and necrotizing enterocolitis.20 In another cohort of 66 gastroschisis cases 
from Texas, evidence of growth restriction, defined as birth weight less than 3%, was not 
found to be associated with longer length of stay or longer total parenteral nutrition,21 
despite the fact that SGA neonates in that cohort were more likely to require delayed 
closure. Reasons for the prolonged hospitalization in our SGA cohort remain unclear, as 
there were no differences in gestational age, type of closure, sepsis or bowel atresia 
between the groups. However, the finding of significantly increased rate of prolonged 
mechanical ventilation in the SGA group may suggest associated clinical variables and 
morbidities. Of note, sepsis was more common among SGA infants compared with AGA 
infants, although the difference did not reach statistical significance likely due to 
relatively small patient numbers.  
The association between gastroschisis and SGA is well known to prenatal 
sonographers, resulting in possible bias and leading to a lower specificity and higher false 
positive rates of prenatal suspected IUGR diagnosis.26, 27 In our cohort, SGA was 
suspected prenatally more frequently in SGA neonates compared with non-SGA 
neonates, and the ultrasound sensitivity and specificity of SGA were 100% and 42% 
within 14 days of delivery and 100% and 35% within 7 days of delivery. The low 
specificity may have resulted from our definition of IUGR, which was an estimated fetal 
weight <10% for gestational age with or without umbilical artery Doppler and amniotic 
fluid abnormalities. Of note, there were no differences in either abnormal umbilical artery 
Doppler findings or oligohydramnios between the study groups, but we were likely 
underpowered to study those outcomes. Others have noted a similar low specificity for 
prenatal IUGR diagnosis in gastroschisis cases, with ultrasound predicting IUGR in 43% 
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of cases in one study but SGA present in only 23%.26 A study by Ajayi et al. also found 
that only 50% of fetuses with abdominal circumference<2.5th percentile were SGA at 
birth.27 In contrast, the reported sensitivity for SGA prediction in non-gastroschisis cases 
ranges from approximately 64% to 85%, with a specificity of 63–94%.13,14 An ultrasound 
diagnosis of suspected IUGR may be inaccurate for SGA determination in cases of fetal 
gastroschisis because the abdominal circumference is often smaller than expected due to 
a large amount of bowel being located outside of the abdominal cavity.28,29 In addition, it 
has been shown in a non-gastroschisis population that the SGA versus AGA comparison 
used does not properly reflect the percentage of body fat among these infants.30 Given 
that the finding of IUGR may prompt iatrogenic preterm delivery in pregnancies with 
gastroschisis, it is important to develop more reliable methods of predicting SGA.  
Our study is not without limitations. First, our approach was a retrospective 
review along with its inherent biases. We included all cases of prenatally diagnosed 
gastroschisis that received both prenatal and postnatal care in our centers during the study 
period, and it is possible that ascertainment bias exist; specifically, some prenatal 
stillbirth cases may have occurred before an initial referral to our centers could occur, and 
their data are therefore not included in the analysis. In accordance with this limitation, we 
had no cases of prenatal stillbirth in either group in either institution while the stillbirth 
rate described in other cohorts ranges from 1% to 3%.10,11 Also, our centers do not 
employ a common standardized algorithm for the prenatal and postnatal management of 
gastroschisis, and therefore, approach to care may have been individualized. 
Unfortunately, the use of umbilical artery Doppler was not standardized in either 
institution, thus limiting the interpretation of this data. Sample size limitations prevented 
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an analysis of the effects of individual provider factors on perinatal and neonatal 
outcomes and we were possibly underpowered to see certain rare adverse neonatal 
outcomes. Finally, SGA at delivery may not indicate pathological growth, but rather 
constitutional growth in some cases.25 Unfortunately, we were unable to analyze 
additional factors associated with pathological growth that might have confounded the 
results including certain prenatal Doppler abnormalities or postnatal assessments, such as 
the ponderal index, because those were not universally collected in our centers.  
Strengths of the analysis include the relative size of the cohort and the inclusion 
of detailed prenatal, perinatal and neonatal data from two large referral centers, thereby 
making our results more generalizable. By focusing on ‘true SGA’ at birth, and not 
suspected IUGR based on prenatal ultrasound, we were able to analyze the effect of 
likely pathological growth on both perinatal and neonatal outcomes. Our finding of an 
independent association of SGA and prolonged neonatal LOS may help providers counsel 
their patients and warrants further study as to possible underlying etiologies. 
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Abstract 
Objective: To investigate the association between meconium staining and 
perinatal and neonatal outcomes in pregnancies with gastroschisis. Methods: 
Retrospective analysis of infants with prenatally diagnosed gastroschisis born in two 
academic medical centers between 2008 and 2013. Neonatal outcomes of deliveries with 
and without meconium staining were compared. Primary outcome was defined as any of 
the following: neonatal sepsis, prolonged mechanical ventilation, bowel atresia or death. 
Secondary outcomes were preterm delivery, preterm-premature rupture of membranes 
(PPROM) and prolonged hospital length of stay. Results: One hundred and eight infants 
with gastroschisis were included of which 56 (52%) had meconium staining at delivery. 
Infants with meconium staining had a lower gestational age at delivery (36.3 (±1.4) 
versus 37.0 (±1.2) weeks, p = 0.007), and a higher rate of PPROM (25% versus 8%, p = 
0.03) than infants without meconium. Meconium staining was not significantly associated 
with the primary composite outcome or with any of its components. After adjustments, 
meconium staining remained significantly associated with preterm delivery at <36 weeks 
[odds ratio OR = 4.0, 95% confidence intervals (CI): 1.5–11.4] and PPROM (OR = 3.8, 
95% CI: 1.2–14.5). Conclusions: Among infants with gastroschisis, meconium staining 
was associated with prematurity and PPROM. No significant increase in other adverse 
neonatal outcomes was seen among infants with meconium staining, suggesting a limited 
prognostic value of this finding. 
 
Introduction 
Gastroschisis is a congenital abdominal wall defect that occurs in approximately 
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1–5 cases per 10,000 live births [1]. Gastroschisis is commonly diagnosed in utero by 
routine ultrasound that can identify the defect as early as the first trimester [2, 3]. 
Although the overall outcome for infants with gastroschisis is favorable [4], they remain 
at increased risk for multiple peripartum and neonatal complications, including 
intrauterine growth restriction (IUGR), stillbirth, bowel dysfunction, bowel atresia, bowel 
necrosis and short-bowel syndrome [5,6]. Meconium staining at delivery has long been 
known to be associated with gastroschisis, although the exact implications of meconium 
staining remain unclear. There is a wide variation in the documented incidence of 
meconium staining in gastroschisis cases, with prior studies demonstrating rates between 
25% and 83% [6–8]. Prior studies in animal models have suggested that meconium in 
amniotic fluid is related to intestinal damage in infants with gastroschisis [9–11]. In 
addition, a recent cohort study found an increased risk of umbilical ‘‘peel’’ and edema 
among infants with meconium staining [12]. Although prior studies have examined the 
association between meconium staining and neonatal bowel outcomes, reports detailing 
the adverse effects, if any, between meconium and intrapartum and other neonatal 
outcomes are limited. Our objective in this retrospective cohort study was to evaluate the 
association between meconium stained amniotic fluid and perinatal and neonatal 
outcomes among pregnancies with gastroschisis. Because meconium has been described 
to be associated with inflammation, we hypothesized that meconium staining would be 
related to increased adverse antepartum and neonatal outcomes, particularly preterm birth 
and neonatal respiratory effects. 
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Materials and Methods 
Study Population  
We performed a retrospective study of all infants with prenatally diagnosed 
gastroschisis whose mothers received prenatal care at Loma Linda University Medical 
Center and Lucile Packard Children’s Hospital Stanford between October 2008 and 2013. 
Both institutions are tertiary care referral centers in California with expertise in managing 
gastroschisis, including maternal-fetal medicine, pediatric surgery, prenatal ultrasound 
and level IV neonatal intensive care.  
In both institutions, pregnancies complicated by fetal gastroschisis are managed in 
outpatient high-risk pregnancy clinics, with serial ultrasound surveillance and antenatal 
nonstress testing. A delivery prior to 37 completed weeks gestation is indicated in cases 
with severe maternal medical or obstetric complications, or non-reassuring fetal status 
including suspected IUGR or abnormal antenatal testing. In the absence of fetal or 
maternal morbidity, delivery for gastroschisis cases was generally undertaken at 36–37 
weeks (Stanford) or by 38 weeks (Loma Linda) during the study period in order to avoid 
early term stillbirth, the precise timing of which was left to be decided by the primary 
care provider. In both institutions, a trial of labor is preferred over cesarean delivery in 
the absence of obstetric contraindications.  
The study data from both institutions were collected and managed using Research 
Electronic Data Capture (REDCap) [13], a secure, web-based application designed to 
support data capture for research studies. A total of 113 gastroschisis cases were 
identified from separate institutional databases in which pregnancies with fetal anomalies 
are prospectively entered. Cases with missing information on meconium staining (n=5) 
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were excluded from the analysis. Study approval was obtained from institutional review 
boards at Loma Linda University and Stanford University. 
 
Study Definitions  
Detailed perinatal, intrapartum and neonatal variables were collected from 
electronic medical records. Meconium staining of the amniotic fluid was defined 
clinically as the presence of meconium at any point during labor and delivery (both thin 
and thick meconium) by the obstetrical team and documented in the medical record. 
Neonatal prolonged length of stay (LOS) was defined a priori as the upper quartile (≥ 
75th percentile) of LOS (in days) for the entire cohort. Prolonged mechanical ventilation 
was defined similarly a priori as the upper quartile of the total length of mechanical 
ventilation (in days) for the cohort. Diagnosis of neonatal sepsis was based on a positive 
blood culture during initial neonatal hospitalization. Maternal prepregnancy body mass 
index (BMI) was calculated as (BMI = weight in kilograms/height^2 in meters) using 
height and documented prepregnancy weight. Small for- gestational-age (SGA) was 
defined by a birth weight less than 10th percentile at delivery using the Fenton growth 
charts for infants <38 weeks GA [14] and the WHO growth charts for infants ≥38 weeks 
GA [15].  
The primary outcome of the study was a composite neonatal outcome, defined as 
any of the following: culture positive sepsis or presumed infection (as determined 
clinically by the treating neonatologist), prolonged mechanical ventilation, bowel atresia 
(as documented in the medical record by the neonatal or surgical teams) or death prior to 
discharge. Secondary outcomes were the individual components of the primary outcome, 
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preterm delivery at <36 weeks gestation, preterm-premature rupture of membranes 
(PPROM) and prolonged hospital LOS. A preterm gestational age cut-off of 36 weeks 
was chosen because many pregnancies complicated by gastroschisis are iatrogenically 
delivered between 36 and 37 weeks due to concerns about near-term and early term in 
utero demise.  
 
Statistical Analysis  
Statistical analysis was performed using R application (version 2.15.0, R 
Development Core Team, 2011, Vienna, Austria). Unadjusted analyses were performed 
using chi-square test or Fisher’s exact test for categorical variables, and Student’s t-test or 
Wilcoxon rank-sum test for continuous variables, as appropriate. Multivariable logistic 
regression models were constructed to determine the independent association of 
meconium staining with neonatal outcomes while adjusting for gestational age and study 
center. Results of the model were expressed as odds ratios (OR) and 95% confidence 
intervals (CI). The level of significance was set at p <0.05. 
 
Results 
A total of 108 cases with prenatally diagnosed gastroschisis were included in the 
analysis of which 56 (52%) had meconium staining at delivery. Forty-one patients with 
meconium staining (73%) delivered at Loma Linda University and 15 (27%) at Stanford 
University (p = 0.04). No cases of antepartum or peripartum stillbirths were recorded in 
this study. Maternal demographics are shown in Table 2.10. No significant differences 
were seen in maternal age, race/ethnicity, payer status, gravidity or parity, prepregnancy 
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BMI or smoking between the groups with and without meconium staining (Table 2.10). 
Meconium staining at delivery was associated with preterm birth before 37 weeks 
gestation [37 (66%) versus 20 (39%), p = 0.007], preterm birth before 36 weeks gestation 
[20 (36%) versus 9 (17%), p = 0.01] and PPROM [14 (25%) versus 4 (8%), p = 0.03]. 
Mean gestational age at birth was lower in the meconium group [36.3 weeks (±1.4) 
versus 37.0 weeks (±1.2) (p = 0.007)] (Table 2.11). No significant difference was found 
in the incidence of oligohydramnios, abnormal umbilical artery Doppler or in the mode of 
delivery at term or at <36 weeks gestation (spontaneous preterm birth 14% versus 10% in 
no meconium; induced labor 11% versus 4% in no meconium, p = 0.79) between the 
groups (Table 2.11). No significant difference was found in the rate of preterm delivery at 
<36 weeks in regards to the study center [24 (33%) in Loma Linda versus 8 (20%) in 
Stanford, p = 0.75] and the mode of delivery <36 weeks was similar between the study 
centers [spontaneous, n =9 (12%) in Loma Linda versus n =4 (10%) in Stanford; induced 
n =4 (5%) versus n =4 (10%) in Stanford; scheduled C-section n =7 (10%) versus 0% in 
Stanford]. Indications for labor induction at <36 weeks were similar between the two 
centers [Loma Linda: non-reassuring fetal testing (n =1); PPROM (n =3) and other (n =1) 
versus non-reassuring fetal testing (n =2), PPROM (n =2) and other (n =1) in Stanford]. 
The indications for scheduled C-section in Loma Linda were non-reassuring fetal status 
(n =5) and other (n =3). In addition, no significant difference was found in the rate of 
meconium staining at deliveries <36 weeks between the study centers [n =16 (22%) in 
Loma Linda versus n =4 (10%) in Stanford, p =0.21]. No significant difference was seen 
in the unadjusted rate of primary composite outcome between the meconium staining and 
no meconium staining groups [26 (46%) versus 18 (35%), p =0.29]. In unadjusted 
 58 
analyses, neonates with gastroschisis and meconium staining required longer duration of 
mechanical ventilation [median 9 days (1–31) versus 3 days (1–58), p =0.002], and were 
more likely to receive delayed abdominal closure (75% versus 56%, p =0.04) compared 
to those without meconium (Table 2.12). No significant difference was noted in neonatal 
birth weight or incidence of SGA between the two groups (Table 2.12). Similar rates of 
bowel atresia, neonatal sepsis/infection, prolonged hospital LOS and prolonged 
mechanical ventilation were also noted for the groups with meconium and without 
meconium staining (Table 2.12). After adjusting for gestational age and study center in 
multivariable models, meconium staining was not related to primary composite outcome 
or any of its individual components (Table 2.13). After adjusting for study center, both 
preterm delivery <36 weeks (OR =3.3, 95% CI: 1.2–10.3) and PPROM (OR =4.0, 95% 
CI: 1.5–11.4) remained significantly related to meconium staining, respectively (Table 
2.13).  
 
 59 
Table 2.10. Maternal demographics in pregnancies with 
gastroschisis and meconium staining compared to no 
meconium staining. 
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Table 2.11. Perinatal findings and outcomes of gastroschisis 
pregnancies with meconium staining compared to no meconium 
staining. 
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Table 2.12. Neonatal outcomes in pregnancies with gastroschisis 
and meconium staining at delivery compared to no meconium 
staining. 
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Table 2.13. Association between neonatal outcomes and 
meconium staining among infants with gastroschisis. 
 
 
Discussion 
In this study, no significant difference was seen in the rate of bowel atresia, 
neonatal sepsis/infection, prolonged LOS or prolonged mechanical ventilation. The 
current study adds to the existing literature, as meconium staining in infants with 
gastroschisis was associated with preterm birth at <36 weeks and PPROM.  
In the non-gastroschisis population, up to 20% of live births are complicated by 
meconium staining [16, 17]. Among term pregnancies without gastroschisis, meconium 
staining has shown to have limited predictive value for poor neonatal outcomes, with 
some studies showing an increased rate of adverse outcomes in neonates with meconium 
staining [16] and others demonstrating no significant association with perinatal asphyxia 
or neonatal neurologic outcome [18–20]. Among infants with gastroschisis, meconium 
rates of up to 25–83% have been reported [6–8]. In the current study, 52% of the infants 
with gastroschisis had meconium staining at delivery, which is consistent with that of the 
recent study from the University of California database [6]. The variation in the rates of 
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meconium staining among prior studies may reflect differences in definition of 
meconium staining and differences in baseline meconium staining between institutions. 
Unfortunately, baseline rates of meconium were not available in either center, as those 
are not routinely tracked for clinical or quality assurance purposes. Even in this study, a 
difference in the rate of meconium staining was found between the two centers (27% 
versus 73%), although both are consistent with reported rates in the literature.  
Studies analyzing the association between meconium staining and adverse 
neonatal outcomes have been previously reported. In a study of 191 infants with 
gastroschisis by Overcash et al., no significant relationship between meconium staining 
and a composite adverse outcome including neonatal death, bowel complications 
requiring re-operation, gastrostomy or necrotizing enterocolitis was found [6], a finding 
which is consistent with our results. Another study demonstrated an association between 
meconium staining and abnormal cardiotocography and/or SGA [7], which was not seen 
in our study. Although neonates with gastroschisis and meconium staining demonstrated 
significantly increased days on mechanical ventilation in unadjusted analysis, there was 
no significant difference in prolonged mechanical ventilation in unadjusted or 
multivariable analyses. The difference in delayed abdominal closure between groups may 
have been driven by the study center, as the decision is not standardized across both 
institutions and the decision on primary versus delayed closure is based on the discretion 
of the treating surgeon.  
In this study, meconium staining among infants with gastroschisis was found to 
be associated with prematurity before 36 weeks’ gestation as well as with PPROM. 
Studies in non-gastroschisis populations have demonstrated that meconium is rarely 
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passed before 34 weeks’ gestation and appears more often as gestational age increases 
[21–23]. Meconium staining is found in approximately 4% of preterm pregnancies in 
non-gastroschisis population [24, 25], whereas in our study, 65% of gastroschisis infants 
born at <37 weeks’ gestation demonstrated meconium staining. Underlying etiologies for 
the presence of meconium in preterm gastroschisis cases are unclear, especially since the 
exact timing when the meconium occurred (antepartum versus intrapartum) in our 
population is unknown. Although, meconium staining was significantly related to study 
center in this study, no significant difference was found in the rates of preterm 
pregnancies between the two study centers, nor did the meconium staining and study 
center significantly correlate in a subgroup of deliveries at <36 weeks gestation. One 
possibility could be that meconium stained amniotic fluid enhanced the bowel 
inflammation prior to delivery, thus, leading to spontaneous preterm delivery and preterm 
rupture of membranes. Prior studies in fertilized chick eggs have documented increased 
gastrointestinal inflammation related to meconium stained amniotic fluid [9, 10]. Another 
possibility could be that PPROM itself irritates the exposed bowel leading to meconium 
staining.  
Our study is not without limitations. First, our study design is limited by the 
inherent biases of a retrospective review. Although we included all cases of prenatally 
diagnosed gastroschisis that received prenatal, intrapartum and postnatal care in our 
centers during the study period, it is possible that some prenatal stillbirth cases may have 
occurred before an initial referral to our centers, and therefore their data are not included 
in the analysis. Another limitation is that the meconium staining in this study was defined 
subjectively by the providers at the time of delivery and was not based on standardized, 
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prospectively applied criteria. Moreover, meconium staining was not sub-classified as 
‘‘thick’’ versus ‘‘thin’’ meconium, and it is unclear whether one is more prevalent in 
cases of gastroschisis or more commonly associated with the adverse outcomes we 
analyzed. It is also uncertain whether the meconium was present prior to the onset of 
labor or secondary due to stress during labor, even among cases with PPROM. Our 
centers do not utilize a common standardized algorithm for the prenatal, intrapartum and 
postnatal management of gastroschisis, and therefore approach to care was 
individualized. Lastly, because of the limited sample size, we were underpowered to 
detect certain rare neonatal outcomes in this study, including many of the individual 
variables included in the composite primary outcome. That being said, strengths of our 
study include the relatively large size of the cohort compared to previously published 
studies [7,8,12] and the inclusion of prenatal, perinatal and neonatal data from two 
tertiary referral centers, thereby making our results more generalizable. By comparing the 
perinatal and neonatal outcomes of gastroschisis infants with and without meconium 
staining at delivery, this study brings new important findings to this rather understudied 
question.  
In conclusion, peripartum meconium staining in pregnancies complicated by 
gastroschisis may be associated with preterm delivery and PPROM. However, the lack of 
a strong association between meconium staining and severe adverse neonatal outcomes 
suggests a poor prognostic value to this occurrence. Future studies are needed to establish 
possible mechanism underlying the finding of meconium staining in premature deliveries 
of infants with gastroschisis.  
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Abstract 
OBJECTIVE: To assess the accuracy of different sonographic estimated fetal 
weight (EFW) cutoffs, and combinations of EFW and biometric measurements for 
predicting small for gestational age (SGA) in fetal gastroschisis. STUDY DESIGN: 
Gastroschisis cases from two centers were included. The sensitivity, specificity, positive 
and negative predictive values (PPV and NPV) were calculated for different EFW 
cutoffs, as well as EFW and biometric measurement combinations. RESULTS: Seventy 
gastroschisis cases were analyzed. An EFW <10% had 94% sensitivity, 43% specificity, 
33% PPV and 96% NPV for SGA at delivery. Using an EFW cutoff of <5% improved the 
specificity to 63% and PPV to 41%, but decreased the sensitivity to 88%. Combining an 
abdominal circumference (AC) or femur length (FL) z-score less than − 2 with the total 
EFW improved the specificity and PPV but decreased the sensitivity. CONCLUSION: A 
combination of a small AC or FL along with EFW increases the specificity and PPV, but 
decreases the sensitivity of predicting SGA. 
 
Introduction 
Gastroschisis is a severe paraumbilical abdominal wall defect that occurs in 
approximately one to five cases per 10 000 live births.1 Fetal gastroschisis is commonly 
diagnosed in utero by routine ultrasound starting as early as the first trimester. 
Approximately 15 to 30% of fetal gastroschisis cases are born small for gestational age 
(SGA) less than 10% for gestational age.2–7 Although the etiology of SGA among 
gastroschisis cases remains unclear, it may be an intrinsic part of gastroschisis physiology 
with some investigators suggesting involvement of the vascular endothelial growth 
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factor–nitric oxide synthase 3 pathway.3,8 SGA is associated with adverse neonatal 
outcomes including prolonged neonatal intensive care unit length of stay, and surgical 
complications including perioperative infections and delayed closure of the abdominal 
wall defect.2,4,9 Therefore, accurately predicting SGA prenatally is important for patient 
counseling and delivery planning.  
The incidence of suspected intrauterine growth restriction (IUGR) less than 10% 
by prenatal ultrasound in gastroschisis cases is found in 50 to 75% of pregnancies, higher 
than the incidence of SGA at birth.2,10 Intrauterine growth restriction often begins in the 
second trimester, and is driven largely by the fact that the herniated viscera lead to 
decreased abdominal circumference (AC), which is one of the major component of 
different estimated fetal weight ultrasound formulas.4,11–14 Numerous studies, including a 
recent study by our group, have assessed the predictive utility of the total estimated fetal 
weight (EFW) in predicting SGA at birth in gastroschisis cases.2,4,10,11 Most have shown 
that prenatal ultrasound generally underestimates the actual birth weight, especially when 
the common Hadlock formula is used, resulting in high false-positive rates.4,10–12 Given 
the high sensitivity but more modest specificity of prenatal ultrasound, improving the 
accuracy of SGA prediction in these cases is warranted. The aim of our study was to 
assess the accuracy of different EFW cutoffs, and combinations of EFW and biometric 
measurements for predicting SGA in gastroschisis cases.  
 
Materials and Methods 
Study Population 
This was a retrospective study of all infants with prenatally diagnosed 
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gastroschisis whose mothers received prenatal care at Loma Linda University Medical 
Center and Lucile Packard Children’s Hospital Stanford between 2008 and 2013. Both 
institutions are tertiary care referral centers in California with maternal–fetal medicine, 
prenatal ultrasound, level IV neonatal intensive care units and pediatric surgical expertise 
in the management of gastroschisis.  
Gastroschisis cases were identified from separate institutional databases in which 
pregnancies with fetal anomalies are prospectively entered. Only cases with information 
on SGA diagnosis were included in the current analysis. Pregnancies complicated by fetal 
gastroschisis are managed in outpatient high-risk pregnancy clinics in both centers, with 
serial ultrasound surveillance and antenatal non-stress testing. Indications for iatrogenic 
preterm delivery include severe maternal medical or obstetric complications, or non-
reassuring fetal status including suspected IUGR or abnormal antenatal testing. In the 
absence of associated fetal or maternal morbidity, delivery for gastroschisis cases is 
typically recommended between 36 0/7 and 37 6/7 weeks in both institutions in order to 
avoid term stillbirth, although the precise timing of which is left to the discretion of the 
primary care provider. A trial of labor is preferred over cesarean delivery in the absence 
of obstetric contraindications.  
Study data from both institutions were collected and managed using Research 
Electronic Data Capture (REDCap), a secure, web-based application designed to support 
data capture for research studies. Institutional review board approvals from both Loma 
Linda University and Stanford University were obtained prior to initiation of the study.  
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Study Definitions  
Detailed perinatal, intrapartum and neonatal variables were collected from 
electronic medical records. In addition, ultrasound reports and stored ultrasound images 
were reviewed by trained research nurses and physicians. The prenatal EFW was 
assessed using a Hadlock formula incorporating the biparietal diameter (BPD), head 
circumference (HC), AC and femur length (FL) (Log10 (weight) = 1.3596 − 0.00386 × 
AC × FL +0.0064 × HC+0.00061 × BPD × AC+0.0424 × AC+0.174 × FL).14 The EFW 
percentile for a given gestational age was then estimated using a Hadlock EFW percentile 
calculator.12, 13 Only cases with ultrasound assessment 2 weeks prior to delivery were 
included in the analysis. Doppler studies of the ductus venosus, umbilical vein or middle 
cerebral artery are not routinely performed in prenatally diagnosed cases of fetal 
gastroschisis in either center, and umbilical artery Doppler assessment is only performed 
in cases of suspected IUGR (EFW<10%). Maternal pre-pregnancy body mass index was 
calculated as (body mass index = weight in kilograms/height2 in meters) using height and 
documented weight at pre-pregnancy. SGA was defined by a birth weight less than 10th 
percentile at delivery using gender-specific Fenton growth charts for infants.15  
Statistical Analysis  
To account for differences in the gestational age at the last scan between the 
patients, Z-scores were calculated for the different biometric measurements. Z-scores 
(assessment of the standard deviation from the expected mean for gestational age) for 
individual sonographic parameters were calculated based on published formulas 
incorporating the gestational age at the time of the ultrasound exam.12 Statistical analysis 
was performed using Stata/SE 14.1 (Stata Corp. College Station, TX, USA). Unadjusted 
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analyses were performed using χ2 test for categorical variables, and Student’s t-test for 
continuous variables. Receiver operating characteristic curves, sensitivity, specificity, 
positive predictive value (PPV) and negative predictive values (NPV) were calculated for 
the total EFW and individual biometric parameters. EFW less than the 5th and 10th 
percentiles were considered as cutoffs for estimating diagnostic parameters. The level of 
significance was set at P <0.05. Area under the curve was estimated using logistic 
regression with individual or combination of biometric parameters as predictor variables.  
 
Results 
Of 178 total gastroschisis cases managed in our centers during the time period, we 
excluded 108 cases that did not have an ultrasound performed within 2 weeks of delivery, 
yielding a total of 70 cases for analysis. Of those, 16 infants (23%) were determined to be 
SGA at birth. When comparing baseline demographic data between the SGA and 
appropriate for gestational age (AGA) groups, there was no difference in mean maternal 
age (21.2 vs 21.6 years, P=0.78), the gestational age of the last ultrasound exam (35.9 vs 
35.2 weeks, P = 0.14), days between the last ultrasound exam and delivery (6.0 vs 5.8, P 
= 0.91), or the gestational age of delivery (36.8 vs 36.0 weeks, P = 0.12) between those 
with and without SGA. Women with and without SGA neonates had similar pre-
pregnancy body mass index (22.5 vs 27.4, P = 0.30) (Table 2.14).  
The mean EFW and individual biometric parameters were compared between 
those with and without SGA at delivery (Table 2.15). There was a statistically significant 
difference between the mean AC in the SGA group when compared with the AGA group 
(27.0 vs 28.9 cm, P = 0.020). All of the other parameters, including the mean EFW were 
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found to be similar between the groups. When considering EFW percentile, SGA 
neonates had significantly lower EFW percentile (3.8 percentile) compared with AGA 
neonates (16.5 percentile, P = 0.021). Gestational age-specific Z-scores for the individual 
sonographic parameters were compared between SGA and AGA neonates (Table 2.16). 
There was a statistically significant difference between the z-score of the AC (−3.4 vs − 
1.6, P <0.0001) and FL (−2.3 vs − 1.6, P = 0.013) between the groups. The other 
parameters, HC and BPD, were similar between groups. Prediction of SGA was assessed 
using receiver operating characteristic analysis along with the sensitivity, specificity, 
PPV and NPV of the total EFW and individual parameters using z-scores less than − 2, 
which is consistent with less than 5% for gestational age (Table 2.17 and Figure 2.3). An 
EFW less than 10% had 94% sensitivity, 43% specificity, 33% PPV and 96% NPV for 
SGA at delivery. Thirty-four cases had a prenatal sonographic EFW less than 5% for 
gestational age, 14 of whom were born SGA. Using an EFW cutoff of < 5% improved the 
specificity to 63% and PPV to 41% but decreased the sensitivity to 88%. The only 
individual parameter with similar area under the curve was an AC z-score less than − 2.  
In order to study the predictive utility of biometric measurements, we then 
analyzed different combinations of EFW cutoffs and parameters with a z-score less than 
− 2. Combining an EFW less than 5% and AC z-score less than − 2 (requiring both to be 
true to predict SGA) increased the specificity from 61–63 to 72%, with a decrease in 
sensitivity from 88 to 81% when compared with the EFW less than 5% alone. The 
combination of EFW less than 5% and AC z-score less than − 2 also yielded a higher 
PPV (46%) and similar NPV (93%) compared with the EFW alone. Adding an FL z score 
less than − 2 to the EFW less than 5% (requiring both to be true to predict SGA) 
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increased specificity to 77%, but dramatically decreased the sensitivity to 56% and NPV 
to 85% when compared with the EFW less than 5% alone. A combination of EFW less 
than 5%+AC z-score less than − 2+FL z-score less than − 2 (requiring all three to predict 
SGA) increased specificity to 91%, but decreased the sensitivity to 25% and the NPV to 
80% when compared with the total EFW less than 5% alone.  
 
Table 2.14. Maternal demographic and obstetric factors in SGA and AGA 
gastroschisis cases. 
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Table 2.15. Total estimated fetal weight (EFW), head circumference (HC), 
biparietal diameter (BPD), abdominal circumference (AC), femur length (FL) 
at the last ultrasound before delivery.  
 
 
 
Table 2.16. Mean z-scores for individual sonographic biometric parameters 
and risk of small for gestinational age (SGA).  
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Table 2.17. Sensitivity, specificity, positive predictive value (PPV) and 
negative predictive value (NPV) of the total estimated fetal weight (EFW) and 
individual sonographic parameters and combination of parameters for 
prediction of small for gestational age. 
 
.  
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Figure 2.3. Prediction of SGA at delivery among fetuses with gastroschisis using the 
third trimester estimated fetal weight (EFW) and biometric measurements (AC, FL, BPD, 
HS). AC, abdominal circumference; BPD, biparietal diameter; FL, femur length; HC, 
head circumference; ROC, receiver operating characteristic; US, ultrasound. 
 
Discussion 
In this multi-institutional cohort of gastroschisis cases we found differences in 
sonographic AC and FL z-scores within 2 weeks of delivery between SGA and AGA 
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infants. However, the addition of a very short AC or FL with a z-score less than − 2 to the 
overall EFW increased the specificity and PPV of prenatal ultrasound, but decreased the 
sensitivity compared with the EFW alone. Our findings have several important 
contributions to the existing literature and potential clinical implications. First, our data 
showing a smaller FL in addition to the expected smaller AC support the theory that 
prenatal IUGR may be an intrinsic part of gastroschisis physiology. In their study of 70 
gastroschisis cases, Centofanti et al.16 found that fetal measurements of HC, AC and FL 
were all smaller during the second half of the pregnancy in fetuses with gastroschisis 
compared with normal controls. The etiology for SGA in gastroschisis cases deserves 
further research, but the mechanism is likely intrinsic to the fetus rather than placental 
since prior studies found similar rates of oligohydramnios and umbilical artery Doppler 
flow abnormalities between SGA and AGA cases.2 In their study of 42 gastroschisis 
cases undergoing long-term follow-up (median age 9), Harris et al.17 described 
significant catch up growth between birth and follow-up for the majority of children; 
however, those with complex gastroschisis (bowel complications such as atresia and 
volvulus) at birth had a significantly lower median body mass index and weight z-scores 
at follow-up.  
Second, our data provide clinicians comprehensive data about the predictive 
utility of different EFW cutoffs, and combinations of EFW and small biometric 
measurements in predicting SGA at delivery. Multiple studies have shown the relatively 
poor accuracy of prenatal ultrasound in predicting SGA irrespective of EFW formulas.6, 11 
In their study of 53 gastroschisis cases, Nicholas et al.11 compared the Honarvar, Siemer 
and Hadlock formulas for EFW. While none of the three formulas met the criteria for 
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ideal formula (low systematic error and high precision) the authors found the Hadlock 
formula to have the best bias and precision combination. In a similar study of 62 
gastroschisis cases with an ultrasound performed within 2 weeks of delivery, Chaudhury 
et al.6 compared the accuracy of five different EFW formulas. They found similar 
accuracy rates using the Hadlock formula (89% sensitivity and 68 to 70% specificity) but 
higher specificity (up to 86%) and positive predictive value (67%) when using either the 
Shepard or Siemer formulas. In our study, we showed increased specificity and PPV with 
using an EFW cutoff less than 5% compared with o10% although at a slightly decreased 
sensitivity. We also showed that adding an AC or FL z-score less than −2 to the overall 
EFW irrespective of cutoff using a Hadlock formula may improve the specificity and 
positive predictive rate as well but at a cost of decreasing the sensitivity. It is unclear if a 
similar effect can be seen by using the Shepard or Siemer formulas. 
Whether improving SGA prediction in the late preterm period will improve 
prenatal management and neonatal outcomes warrants further investigation. In a recently 
published study analyzing prenatal, intrapartum and neonatal differences between SGA 
and AGA gastroschisis cases, we found no difference in preterm premature membrane 
rupture rates, preterm delivery rates, meconium staining, or mode of delivery between 
SGA and AGA cases.2 That being said, it is plausible that prenatal providers suspecting 
IUGR at later preterm gestational ages may iatrogenically induce gastroschisis 
pregnancies prematurely in order to avoid stillbirth. Several studies have correlated 
earlier gestational age at delivery with adverse neonatal outcomes among gastroschisis 
cases, but prospective implementation of our findings is warranted to assess whether a 
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later gestational age of delivery can be achieved by optimizing the accuracy of prenatal 
ultrasound.18–20  
Our study is not without limitations. This was a retrospective study utilizing 
existing records, and the protocol for ultrasound surveillance was not standardized across 
both institutions. Thus, it is possible that selection bias exists in our data set since 
providers concerned about IUGR may have been more likely to perform an ultrasound at 
late preterm gestational ages. That being said the rate of SGA seen in our cohort is 
consistent with other published cohorts, and at worst this bias may have affected the PPV 
and NPV, but not the sensitivity and specificity. Moreover, while other studies have 
suggested that the Hadlock formula may not be the ideal formula for IUGR determination 
in gastroschisis cases, given its wide prevalence in many prenatal diagnostic centers and 
prior gastroschisis studies we specifically targeted this formula.4, 6, 10, 16 Additional studies 
would be needed to study our approach using additional EFW formulas. Finally, we 
assessed different methods of predicting SGA at delivery and not necessarily additional 
neonatal morbidity. The predictive utility of sonographic assessments for adverse 
neonatal outcomes will be the topic of future analyses.  
Despite these limitations, it is important to note the strengths of our study. First, 
given the relatively low incidence of gastroschisis (1 in 2000 to 1 in 3000 pregnancies) 
we provided data from a robust cohort analyzing both the accuracy of the total EFW and 
individual ultrasound parameters within 2 weeks of delivery. In fact, the average days 
from ultrasound to delivery in our cohort was less than 7 days. Second, we used a 
commonly used gender specific neonatal weight nomogram (the Fenton curve) to 
diagnose SGA, and used calculations provided by Hadlock and colleagues to determine 
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the z-scores of individual biometric parameters. This allowed us to present the accuracy 
of individual parameters, the total EFW, and a combination of the EFW and individual 
parameters. Finally, combining data from two separate institutions makes our findings 
generalizable to other sites using the Hadlock formula to determine the EFW.  
In conclusion, adding third trimester AC or FL with a z-score less than − 2 to the 
total EFW improves the specificity and PPV for suspected SGA in gastroschisis cases, 
but lowers the overall sensitivity. Our data can assist providers suspecting IUGR in the 
third trimester in pregnancies complicated by fetal gastroschisis.  
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CHAPTER THREE 
ENVIRONMENTAL TRENDS OF GASTROSCHISIS 
 
Abstract  
 
Increased prevalence of gastroschisis has been linked to environmental factors 
and teratogens, as well as the presence of clustering of cases in North Carolina, Texas, 
the state of Washington and California. Geographic Information Systems (GIS) was 
utilized to identify not only where gastroschisis cases are referred from to Loma Linda 
University Medical Center, but also what is occurring in those surrounding areas. We 
mapped out known cases, overlayed environmental factors such as farmlands, superfund, 
and toxic release inventory sites, then used spatial statistics to quantify the presence of 
hot spots. Hot spot analysis and Gettis-Ord statistics showed areas of high gastroschisis 
case density, or cluster occurrence by noting a high z-score of 5.89 and low p-value of 
0.00, indicating that it is statistically significantly unlikely that the observed spatial 
pattern reflects a random pattern. This study demonstrates the importance of 
geoinformation technology and the usefulness of the spatial scan statistics in exploratory 
etiologic research.  
 
Introduction 
Gastroschisis is a congenital birth defect of the abdominal wall, resulting in 
external herniation of intestines and potentially other abdominal organs.1 Given its 
increase in prevalence worldwide, examining geographic distribution of birth defects, 
such as gastroschisis, can aid in exploratory etiologic research.2 By identifying clusters of 
defects, environmental risk factors may help in the understanding of underlying factors 
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contributing to gastroschisis etiology. 3 In California, a slightly elevated risk of 
gastroschisis was reported4 and potential clustering of cases was considered, given the 
increased prevalence of cases particularly in the Inland Empire region of Southern 
California when compared to the entire State of California. The highest incidence 
appearing to be concentrated in the agricultural and inland areas, with San Bernardino 
and Riverside County having approximately twice the incidence of the coastal regions. 
During the 17 year study period in the State of California, the overall birth prevalence 
increased by 3.2-fold.5 This study by Vu et al. demonstrated that the birth prevalence of 
gastroschisis has been gradually rising in the past two decades in California. 
Additionally, in San Bernardino and Riverside Counties of Southern California, annual 
rates of gastroschisis were noted as 3.2 and 6.0 per 10,000 live births and fetal deaths in 
the years 2005 and 2006, respectively.6 Various environmental risk factors, including 
potential teratogens such as organic solvents and residence surrounding landfill sites, 
have been linked to the increasing rates of gastroschisis due to increased prevalence and 
tendency to occur in clusters. 5, 7-11 The implication of environmental factors is also 
supported by evidence from animal models.12-18  
Geographic Information Systems (GIS) was utilized to analyze geographic trends 
of gastroschisis to determine whether geographic clustering of gastroschisis cases is 
present, and whether any associations with environmental factors, such as waste disposal 
sites, water supply, power lines, and toxic chemicals, exist.   
 
Materials and Methods 
 
Institution review board approval was granted to conduct a retrospective chart 
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review at Loma Linda University Medical Center on gastroschisis cases (n= 257) in order 
to determine rates during a 14 year time period (1998- 2012) in the Inland Empire Region 
of Southern California. 
 
Data Management/Analysis 
Data Sorting 
To ensure patient anonymity and to protect privacy, data for maternal residence 
was sorted by geo-codes.  
 
Geographic Information Systems (GIS) Analysis and Methodology 
Evidence of geographic clustering was evaluated by the distribution of individual 
gastroschisis cases using zip codes (nominal) of maternal residence. Potential temporal 
clustering of gastroschisis was sought by tabulating the frequency of zip codes during the 
1998-2012 time frame. GIS software packages, including ArcMap and ClusterSeer2, and 
statistical methods (Gettis-Ord Statistics) was used to determine and display the 
associations between spatial-environmental and spatial-temporal factors and the 
incidence of gastroschisis. A GIS visual map displayed results of the analysis. 
Additionally, the approximate date of conception and the mother’s residence just prior to, 
at the time of, and/or immediately after conception was recorded to facilitate GIS analysis 
of the incidence of gastroschisis in the study area. It is believed that the teratogen needs 
to be present before the time of the anterior abdominal wall development in order to 
create this defect.  It is anticipated that exposure to teratogens prior to the period of gut 
formation produces metabolites which are responsible for the gastroschisis anomaly. The 
mother’s location(s) were geocoded and aggregated to a larger geographical area using 
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“Centrus” Desktop. Emission site locations were also geocoded at the street level. The 
rationale for this investigation was to identify any associations between gastroschisis and 
environmental toxins from archived United States Environmental Protection Agency 
(EPA) voluntary sites, superfund sites, current industries, and agencies reporting 
permitted emission releases, as well as proximities to agricultural spraying zones and 
freeway corridors (air, soil, and water).  
 
Spatial Analysis 
Part 1: Map out which areas cases are coming from to get a visual representation 
of geographic distribution of gastroschisis cases coming to Loma Linda University 
Health.  
Part 2: Testing for spatial clusters and association of gastroschisis cases and a 
possible environmental association. Farmlands, superfund sites and Toxics Release 
Inventory (TRI) sites as deemed by the EPA were used as overlays to note any 
environmental associations.   
Part 3: Hotspot analysis was conducted to show areas of density (high or low) and 
likeliness of clustering patterns. Spatial statistical tests (Gettis-Ord Statistics) was run to 
determine the statistical probability of the observed spatial pattern occurring as a 
statistically random or non-random pattern.  
 
Results 
 
Spatial analysis shows possible geographic clustering surrounding major 
transportation routes, suggesting environmental or chemical contaminants contributing to 
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increased gastroschisis cases. Additionally, visual inspection reflects a greater density of 
cases surrounding the high desert (Victorville), Palm Springs, Highland, and Jurupa 
Valley areas (Figure 3.1).  The Loma Linda University Medical Center (LLUMC) 
gastroschisis coded cases are overlayed with noted farmlands in Figure 3.2 depicting the 
proximity of gastroschisis incidence to known agricultural/ farmlands. EPA- deemed 
superfund and TRI sites were then added an added overlay (Figure 3.3) showing that 
superfund site placement does seem to visually indicate a relationship of association with 
gastroschisis case incidence. Upon visual inspection, hot spot analysis and Gettis-Ord 
statistics show areas of high density or cluster occurrence. A high z-score of 5.89 and low 
p-value of <0.0001 indicates that it is statistically significantly unlikely that the observed 
spatial pattern reflects a random pattern (Figure 3.4).  
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Figure 3.1. Geographic Information Systems map of cases of neonatal gastroschisis 
graphed for in the Inland Empire region of Southern California.  
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Figure 3.2. A map displaying areas where gastroschisis patients presented at Loma Linda 
University Medical Center (LLUMC) (green region) overlayed with noted farmlands 
(black region). *It is important to note that this map only represents patients seen at 
LLUMC and further research should consider Los Angeles, Orange, Central Valley and 
San Diego counties.  
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Figure 3.3. Gastroschisis GIS Mapping- Cases at LLUCH by Zip Code Overlayed 
with Farmlands, Superfund, and Toxics Release Inventory (TRI) Sites. Data sources: 
LLUCH and TOXMap from EPA.gov (Updated May 2017) 
 94 
 
 
 
 
 
 
 
 
Figure 3.4. Hotspot map of gastroschisis cases at LLUCH by Zip Code showing areas 
of cold spot (low density) to hot spot (high density) occurrence of clustering.  
Gettis-Ord Statistics (General G Summary)    
    
Observed General G:          0.000021 
Expected General G:           0.000014 
Variance:                             0.000000 
z-score:                               5.891194 
p-value:                               0.000000 
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Discussion 
 
We sought to utilize GIS and statistical analyses to assess the relationship 
between the built environment and gastroschisis in the Inland Empire Region of Southern 
California. Investigating the geographic distribution of this birth defect can be useful in 
exploratory research. Elucidating prenatal predictors of gastroschisis is key to improving 
diagnosis. While spatial analysis shows possible geographic clustering surrounding major 
transportation routes, suggesting environmental or chemical contaminants contributing to 
increased gastroschisis cases, it is vital to note the limited sample size and usage of cases 
only admitted at Loma Linda University Medical Center. These data give a snapshot into 
gastroschisis cases in this catchment area, yet fail to consider other potential cases 
referred to surrounding facilities. This limitation can be overcome by accessing San 
Bernardino County birth records, or birth certificate data from the California Department 
of Public Health Vital Records. 
In trying to identify what is causing the clustering of gastroschisis cases, various 
factors were considered. Riverside, San Bernardino, and Ontario, CA being listed as 
number three on the list of “The 10 Most Air-Polluted Cities in the U.S.” by the World 
Health Organization (WHO) in 2011 may indicate environmental associations. In 
addition to traffic and pollution from major transportation routes and agriculture areas in 
the Inland Empire, socioeconomic status was also taken into account.  
This study demonstrates the usefulness of spatial scan statistics in exploratory 
etiologic research and can potentially lead to earlier prenatal diagnoses, improved clinical 
care, decreased morbidity, and potential to reduce health disparities through the use of 
geoinformation technology. 
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Further study should be directed at specific geographic data and determining 
spatio-temporal associations between gastroschisis case clusters and environmental toxins 
from archived EPA superfund and TRI sites. Additionally, using county wide data may 
also increase the sample size and offer a more accurate representation of gastroschisis 
occurrences within California’s Inland Empire region. 
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CHAPTER FOUR 
BIOLOGICAL CONSIDERATIONS OF GASTROSCHISIS 
Abstract  
Objective: Gastroschisis is the most common birth defect of the abdominal wall. 
It manifests as a defect in the anterior abdominal wall located most commonly to the right 
of the umbilicus with evisceration of abdominal viscera. The etiology is unknown and 
various theories have been proposed.  Environmental teratogens have been implicated as 
possible causative factors in some epidemiologic studies. We sought to determine if 
maternal or cord blood serum or amniotic fluid taken from gastroschisis pregnancies had 
an impact on cell migration. 
Methods: Maternal blood, cord blood, and amniotic fluid were obtained from 
pregnant women and their newborns with gastroschisis and controls at delivery and were 
stored at -800 Celsius.  Endothelial cells were grown to create a confluent monolayer then 
incubated with maternal blood, cord blood, and amniotic fluid.   The samples were 
matched for gestational age and mode of delivery. In vitro scratch assay was utilized. The 
Invitrogen EVOS FL Auto Imaging System is used to capture images of cellular 
movement time.  
Results: Cell migration rates were not significantly different between cells 
incubated with third trimester maternal blood, cord blood, and amniotic fluid (p-value= 
0.66 for 3rd trimester blood, p-value = 0.45 for cord blood, and p- value= 0.47 for 
amniotic fluid).  
Conclusion: There was no difference in cell migration rates between control and 
gastroschisis pregnancies. 
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Introduction  
 
Multiple hypotheses have been proposed for gastroschisis pathogenesis including 
a disruption of the blood supply to the developing abdominal wall, failure of mesoderm 
to form in the body wall, abnormal involution of the right umbilical vein, and 
abnormalities in ventral wall folding.1 
Maternal risk factors that confer susceptibility to gastroschisis include genetic 
polymorphisms relating to angiogenesis, further supporting a vascular hypothesis. 2 Torfs 
et al.’s study of 57 gastroschisis cases and 506 non- malformed controls noted risks 
associated with polymorphisms of 32 genes representing enzymes involved in 
angiogenesis, blood vessel integrity, inflammation, wound repair, and dermal or 
epidermal strength. 3 Therefore, environmental factors, if present in pregnancies affected 
by gastroschisis, may impact cell growth.  
In vitro assays allow for the identification of direct effects on endothelial cell 
function in addition to analysis of isolated processes that contribute to angiogenesis and 
variables such as matrix components in isolation. The in vitro scratch assay, a method to 
study cell migration in vitro, is based on the observation that upon creation of a new 
artificial gap (‘‘scratch’’) on a confluent cell monolayer, the cells on the edge of the 
newly created gap will move toward (or away from) the opening to close the ‘‘scratch’’ 
until new cell–cell contacts are established again. Steps involved include creation of a 
‘‘scratch’’ on monolayer cells, capture of images at the beginning and regular intervals 
during cell migration to close the scratch, and comparison of the images to determine the 
rate of cell migration.4 A major advantage of this method is that it mimics migration of 
 101 
cells in vivo which aides in understanding the behavior and patterns of cell migration. 
This understanding may play an important role in the pathogenesis of gastroschisis. 5 
 
Materials and Methods 
Sample Collection 
Maternal blood during the third trimester of pregnancy, and amniotic fluid and 
cord blood at time of delivery were collected in 10 ml heparinized tubes. Blood was 
centrifuged (2000 rcf) at 4 degrees centigrade for 5 minutes to separate the plasma from 
the whole blood. The plasma is then aliquoted and placed in a negative 80 degree C 
freezer. Samples were collected from mothers carrying a fetus diagnosed prenatally with 
gastroschisis. Controls were matched for gestational age at delivery to within ±1 week.      
 
Scratch Assay 
Cell culture dishes were coated with the proper ECM substrate then incubated 
overnight without shaking. The unbound ECM substrate was then removed and washed 
once with Cells Systems media. Dishes were refilled with 3-5 ml of media prior to plating 
the cells grown from Human Brain Microvascular Endothelial Cells. Subconfluent cells 
were resuspended in a tissue culture dish with cells washed twice with Cells Systems 
media, adding versene containing 0.05% trypsin then mixing cells with the medium 
containing serum. The solution was gently pipetted, and the dish was rocked to disperse 
the cells equally. An aliquot from the cell suspension was taken and the cell counts was 
determined using a hemocytometer. Cells were plated onto a prepared 96 well confluent 
cell monolayer plate.  
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The cell monolayer was scraped in a straight line to create a 7 mm “scratch” using a 
20 ml pipet tip to create an artificial gap, or scratch on a confluent cell monolayer plate, 
mimicking the gastroschisis opening as a “wound” (Image 4.1). The debris was then 
removed, and the edge of the scratch will be made uniform by washing the cells once 
with 1 ml of the growth medium then replaced with control, uncomplicated, or 
gastroschisis pregnancy serum in the wells. Wells were photographed at 2 hour intervals 
from 0hr – 8hr, then 24 hrs later using The Invitrogen EVOS FL Auto Imaging System. 
Once all the images were taken, they were analyzed for rate of scratch closure using 
Ilastik6 
 
Statistical Analysis 
A repeated measures ANOVA was performed to compare the area of cell 
migration in normal and gastroschisis samples from third trimester blood, amniotic fluid 
and umbilical cord blood at 0hr, 2hr, 4hr, 6hr, 8hr and 24hrs. We excluded the control 
group as well as results from hour 8 and 24 from analysis due to biological 
insignificance. 
Third trimester maternal blood: Extreme outliers [E11, F11] were excluded from 
the analysis. Hemolysis was noted in 8 samples [Subject A6, B6, C6, D6, E6, F6, G6, and 
F6] and were excluded from analysis.  
Umbilical cord blood: Extreme outliers [E11, F11] were excluded from the 
analysis.  
Amniotic fluid: Extreme outliers [A1 and H1] were excluded from the analysis.  
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Results 
Third trimester maternal blood: Normality assumption was met (Wilks lambda p-
value=0.14). The condition of sphericity (Mauchly's p<0.001) was violated therefore the 
Greenhouse-Geisser Epsilon correction 0.38 suggests reporting multivariate results. A 
mixed model approach using the unstructured covariance model best represented the data 
(AICC unstructured vs Autoregressive heterogeneous p<0.01). There was no significant 
difference between normal and gastroschisis (p=0.66) throughout time in the study.  
Umbilical cord blood: Normality assumption was met (Wilks lambda p-
value=0.47). The condition of sphericity (Mauchly's p<0.001) was violated therefore the 
Greenhouse-Geisser Epsilon correction 0.62 suggests reporting multivariate results. A 
mixed model approach using the unstructured covariance model best represented the data 
(testing unstructured vs Autoregressive heterogeneous demonstrated that the arH model is 
indefensible p<0.01). 
There was no significant difference between normal and gastroschisis (p=0.45) 
throughout time in the study. Exploration of Tukey's post hoc multiple comparison test 
indicated that the average area of the two groups were not significantly different at 
various times but did show that there was significant change within the group over time. 
Amniotic fluid: Normality assumption was met (Wilks lambda p-value=0.49). 
The condition of sphericity (Mauchly's p<0.001) was violated therefore the Greenhouse-
Geisser Epsilon correction 0.81 suggests reporting within subject effect results. A mixed 
model approach using the unstructured covariance model best represented the data 
(testing unstructured vs Autoregressive heterogeneous demonstrated that the arH model is 
indefensible p<0.01). 
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There was no significant difference between normal and gastroschisis (p=0.47) 
throughout time in the study. Exploration of Tukey's post hoc multiple comparison test 
indicated that gastroschisis and normal groups started at hour 0 significantly different 
(p=0.03), and at two other times as well; hour 4 (p=0.005), hour 6 (p=0.002). 
Third trimester maternal blood, cord blood, and amniotic fluid groups over time 
are not significantly different in their cell migration rates (p-value= 0.66 for 3rd trimester 
blood, p-value = 0.45 for cord blood, and p- value= 0.47 for amniotic fluid). Table 4.1, 
4.2, and 4.3 show repeated measures ANOVAs between 3rd trimester maternal blood, 
cord blood, and amniotic fluid of normal and gastroschisis plates throughout four time 
periods, respectively, with corresponding figures showing the average area of wound 
healing over a 24 hour time period. Additionally, Image 4.2, 4.3, and 4.4 show serum 
plated from third trimester maternal blood, cord blood, and amniotic fluid, respectively, 
at 0hr, 2hr, 6hr, 8hr, and 24hr intervals. The scratch closure can be noted, indicating the 
presence of wound healing in all three sample types.  Regardless of the lack of inhibition 
in cell migration rates this was a novel approach to understanding gastroschisis 
development  
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Image 4.1. The cell monolayer scraped in a straight line to create a “scratch”, mimicking 
a wound  
 
 
Table 4.1. Repeated measures ANOVA between 3rd trimester maternal blood of normal 
and gastroschisis plates throughout four time periods. 
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Figure 4.1. Average area of wound healing over a 24 hour time period in third trimester 
blood 
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Image 4.2. Third trimester blood control sample plated in scratch well at 0hr, 2hr, 6hr, 
and 24hr. Scratch closure can be noted indicating wound healing.  
 
 
 
Table 4.2. Repeated measures ANOVA between cord blood of normal and gastroschisis 
plates throughout four time periods.  
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 Figure 4.2. Average area of wound healing over a 24 hour time period in cord blood. 
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Image 4.3. Cord blood from an uncomplicated pregnancy plated in scratch well at 0hr, 
2hr, 6hr, and 24hr. Scratch closure can be noted indicating wound healing.  
 
 
 
Table 4.3. Repeated measures ANOVA between amniotic fluid of normal and 
gastroschisis plates throughout four time periods.  
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Figure 4.3. Average area of wound healing over a 24 hour time period in amniotic fluid. 
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Image 4.4. Amniotic fluid from a gastroschisis pregnancy plated in scratch well at 0hr, 
2hr, 6hr, and 24hr. Scratch closure can be noted indicating wound healing.  
 
 
Discussion  
In vitro scratch assays showed migration of cells in vivo to aid in visualizing 
behavior and patterns of cell migration in control and gastroschisis pregnancies. A 
scratch created in the well mimicked the gastroschisis “wound” and closure rates were 
compared. There were no significant differences found in cell migration rates in third 
trimester maternal blood, cord blood, and amniotic fluid samples between control and 
gastroschisis pregnancies over time. While no or slower rate of cell migration in 
gastroschisis samples were seen, the lack of a significant difference in closure in control 
and gastroschisis samples indicate that cell migration is not affected by factors that may 
be present in late pregnancy in amniotic fluid or in the maternal or fetal circulation. This 
does not eliminate the possibility that incubation taken from samples early in the 
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pregnancy would have yielded different results.  Future work will consider collecting 
biological samples in early stages of pregnancy, or at time of gastroschisis development 
to yield different results as gastroschisis development occurs in the sixth to tenth week of 
fetal development.  
There is need for further understanding the pathogenesis and risk factors 
associated with gastroschisis. Numerous studies have noted factors, such as age, body 
mass index, race, and exposure to toxins (tobacco, alcohol, illicit drugs, and pesticides). 
Still, there has yet to be substantial evidence and correlation in gastroschisis 
development. Despite many hypotheses the pathogenesis of gastroschisis remains 
unknown.  
The exploratory experimental design of this study was aimed to aid in 
understanding gastroschisis formation on a cellular level. The in vitro scratch assay 
approach is a method novel to studies of gastroschisis, yet its ability to capture cell 
migration is key in our investigation of determining cell-cell interactions during cell 
migration. Given that it has been suggested that the defect occurs early in development, at 
the time when, in the area of the defect, there is a shift in vascularization 7 or that there 
may be an interruption of the blood flow in the vascular plexus that will form the right 
vitelline arteries 8, we hypothesized that either process might involve apoptosis, 
angiogenesis, cell migration, or cell adhesion. Additional considerations included 
comparing cell migration rates from samples collected at an earlier gestational age to 
account for disruptions occurring during early development. This may also be connected 
with several environmental factors adversely influencing the process, as well.  
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Tissue formation during embryonic development, wound healing and immune 
responses all require the coordinated movement of cells in particular directions to specific 
locations. Errors during this process have serious consequences, including vascular 
disease, tumor formation and metastasis. An understanding of the mechanism by which 
cells migrate may lead to the development of novel therapeutic strategies for controlling 
cell migration, proliferation, or apoptosis, which may contribute to gastroschisis 
pathogenesis.  
Various biological samples from control and gastroschisis pregnancies were 
examined for differences in cell migration rates. While no significant difference in cell 
migration rates were noted, this adds to our understanding of gastroschisis from a cellular 
framework during embryonic developmental processes. However, further research is 
required to elucidate the mechanisms involved with the development of gastroschisis.  
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CHAPTER FIVE 
CONCLUSIONS 
Our study was unique it that we moved from retrospective chart reviews to 
prospective follow-ups, resulting in longitudinal analysis of 1- year follow-up. We 
noticed a change in maternal demographics. Mothers carrying a baby affected with 
gastroschisis were previously noted as being young in age, nulliparous, and with low 
maternal body mass index (BMI). However, we saw a trend approaching significance of 
an increase in maternal age and parity in mothers of gastroschisis babies over time, while 
BMI was not significantly different. Still, clinically an increased BMI was seen. This 
information aids in clinical practice by increasing awareness of changing maternal 
demographics. Additionally, utilizing data from two institutions we were able to achieve 
a larger sample size to elucidate trends related to LOS and sepsis, depending on mode of 
delivery and type of closure. We saw that cesarean section with labor (CS&L) had a 2.5 
times higher chance of sepsis verses vaginal deliveries, and silo closure yielded an 83% 
increase in sepsis versus primary closures. As the study at Loma Linda University 
Children’s Hospital moved prospective we observed familial recurrences, which was 
interesting given that gastroschisis is not known to have genetic links. A 5.45% sibling 
recurrence rate was noted where a mother had a baby with gastroschisis and a subsequent 
child also affected by gastroschisis. Given this observation, mothers with a previous 
pregnancy affected by gastroschisis should undergo preconception counseling and early 
prenatal care to ensure the best outcomes for her and her baby. Finally, babies with 
complex gastroschisis and delayed times to full feeds were associated with poorer 
outcomes at year one of life. Given the nature of human studies, we are often limited by 
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losing patients at follow- up because they can move, change addresses, and phone 
numbers without informing the hospital. Furthermore, charts contain missing values for 
certain variables we were studying, thus excluding the patient from our study. 
Understanding and utilizing data to elucidate epidemiological trends can play a great role 
in further understanding gastroschisis and its changing characteristics, as well as in 
potentially identifying the best plan of care. Results from this study may aid in clinical 
practice and add to knowledge of gastroschisis demographics, risk factors, and outcomes.   
 Loma Linda University Children’s Hospital (LLUCH) has a unique opportunity to 
further study gastroschisis etiology given its high clustering of cases in the Inland Empire 
region. We noticed that cases at Loma Linda University Medical Center (LLUMC) came 
predominately from the high desert, Victorville area, in addition to Palm Springs, 
Highland, and Jurupa Valley. Furthermore, spatial statistics revealed that, based on the 
cases we utilized, it is statistically significantly unlikely that the observed spatial cluster 
pattern reflects a random pattern. It is important to note that we were limited to cases 
solely for Loma Linda University Medical Center and therefore are not able to account 
for gastroschisis birth are surrounding centers.  
 We compared cell migration patterns from blood and amniotic fluid samples from 
mothers carrying babies with gastroschisis versus control mothers carrying healthy babies 
with an uncomplicated pregnancy to understand gastroschisis at a biological level. Cell 
migration rates did not significantly differ among the gastroschisis and control 
pregnancies in third trimester maternal blood, cord blood, or amniotic fluid group over 
time. Collecting biological samples in early stages of pregnancy may yield different 
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results as gastroschisis development occurs in the sixth to tenth week of fetal 
development.  
 
Future Work 
 
Additional samples, such as maternal hair, were also collected and may be 
analyzed for environmental, chemical, and drug toxicology. Hair analysis has several 
distinct advantages and unique qualities providing it with particular promise in a number 
of regards to biomonitoring.1 Successful analysis can assist in the diagnosis, prognosis, 
and treatment of disease and morbidity, and assess exposure to toxins and polluted 
environments which the body has been exposed to. Substances can remain and be 
analyzed for a longer period of time in hair than traditional blood and urine samples. 
Blood or urine samples are also collected and will be analyzed for metabolites and 
proteomics. Cord blood samples will be submitted to Metabolon2 for metabolic pathway, 
metabolite and biomarker identification. Other studies include the addition of tissue 
sampling of discarded tissue from infant around defect site. For the study group this will 
be from the gastroschisis ring defect at the time of surgical repair of the baby.  For the 
control group the sampling will occur during abdominal wall/scare revisions. To ensure 
neonatal safety, the sampling will only occur if the Pediatric Surgeon determines it 
appropriate. This will not require reconsent as tissue sampling will be done prospectively 
as new subjects are consented. A sample of discarded tissue will be obtained by the 
pediatric surgeon at the time of closure or repair. If there is no tissue to discard, the 
sample will not be obtained. No injuries to infants or mothers are anticipated.  Discomfort 
to baby is no different than what baby is already exposed to during surgical procedure. 
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Anesthesia will be in place and post-operative healing is the same with or without the 
tissue sampling. The addition of the tissue biospecimen help elucidate the 
pathophysiology of gastroschisis. We will compare the vascular morphology in skin and 
rectus muscle samples, measure vascular structure (light microscopy), the relative 
expression levels of several vascular and other cellular proteins (collagen, actin, tubulin, 
by use of advanced epifluorescence and/or confocal microscopy and/or Western 
immunoblot). We also will quantify capillary density with these techniques. 
This biological aspect of the study, coupled with additional geo-temporal and geo-
spatial mapping is needed to move beyond speculation and potentially lead us to a cause.  
Research which further advances the understanding of risk factors or causative 
mechanisms may ultimately result in the prevention of gastroschisis and its related 
morbidities. Once this is known, we can move forward with potential interventions with 
the potential to reduce neonatal health disparities. In addition, our characterization of 
patients in a prospective fashion could lead to better predictors of neonatal outcomes. We 
hope that by studying long term outcome data on these affected individuals, that we will 
be better able to understand their feeding problems and nutritional requirements and 
design an improved treatment program for them. Lastly, this study serves as a tool to 
educate, and increase awareness and knowledge in the population as a whole about 
gastroschisis and its increasing prevalence throughout the world.  
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